JOURNAL TRANSCRIPT

---

Anxiety Across the Lifespan: Practical Integration of Basic and Clinical Approaches

30th Annual Conference

ANXIETY DISORDERS ASSOCIATION OF AMERICA

Baltimore Marriott Waterfront • March 4-7, 2010

FINAL PROGRAM

Jointly sponsored with Tulane University Health Sciences Center – Center for Continuing Education

JERILYN ROSS December 20, 1946 – January 7, 2010 Co-founder, president, and CEO

On behalf of the Board of Directors, Welcome to the ADAA 30th Anniversary Annual Conference. While we are all deeply saddened by the loss of Jerilyn Ross, there is no better way to honor her legacy than by gathering for an event that she nurtured and loved.

own experience as a patient and clinician, she passionately represented our collective voice when speaking on Capitol Hill, at NIMH and other government agencies, with professional and advocacy organizations, and to the media.

ADAA remains unique among mental health organizations, not only for its focus on anxiety disorders, but because it has broad representation across stakeholders. Remaining true to its founding principles, 30 years later ADAA continues as a diverse organization of clinicians, researchers, and consumers.

Under Jerilyn’s leadership, ADAA built a strong foundation by weaving together education, science, training, and treatment. Her dedication helped ADAA secure a place for the field of anxiety disorders. She held a rare perspective on the organization’s beginnings and its future. Along with many members and the Board of Directors, Jerilyn was involved in realigning the organization strategically to engage members more broadly, expand its goals, and build a governance structure that will benefit ADAA for many years to come.

This organization was fortunate to have a visionary leader who made such a profound impact on advancing our professions as well as the field of anxiety disorders. Jerilyn was a tireless advocate and motivating force. Her courage, strength, and compassion brought help and hope to millions of people living with an anxiety disorder. Adding her

It is now up to all of us to carry ADAA forward as Jerilyn’s legacy lives on. Join us in honoring our past and celebrating the future. Jerrold F. Rosenbaum, MD Chair, Board of Directors

Welcome

It is my great pleasure and honor to welcome you to the 30th Anual Conference — the largest conference in the organization’s history. I and the members of the Annual Conference Committee have worked tirelessly to assemble a program that we believe is outstanding in its scope, content, and timeliness. ADAA extends a special thanks to the Conference Committee for their leadership and commitment to the success of the 30th Annual Conference. Daniel S. Pine, MD — chair Jonathan Abramowitz, PhD Gordon J. G. Asmundson, PhD Denise Chavira, PhD Meredith E. Coles, PhD Golda Ginsburg, PhD Philip R. Muskin, MD Simon A. Rego, PsyD Franklin Schneier, MD Naomi Simon, MD, MSc Jasper Smits, PhD Risa Weisberg, PhD Sally Winston, PsyD Daniel K. Winstead, MD

Whether this is your first or 20th visit to our Annual Conference, we hope that you will find the meeting engaging, provocative, and filled with new material. The breadth of content covered in this program is unsurpassed. I hope you will take advantage of the many opportunities to meet your colleagues and network with those who have similar interests. The timing of this year’s conference is bittersweet. Jerilyn Ross, a co-founder and president of ADAA, who passed away in January, was a friend and colleague to many of us. Her loss is a great one, and she will be missed. As clinicians, researchers, family members, or patients affected by anxiety, it is impossible to overestimate the magnitude of the debt we owe Jerilyn for her efforts to focus attention on awareness, treatment, and research of anxiety disorders. At a time when it was taboo to talk openly about mental illness, Jerilyn had the courage to speak out and make a difference. Jerilyn was very proud of how far ADAA had come since its inception as the Phobia Society of America. In many ways, Jerilyn and the field of anxiety disorders grew up together. My own decision to pursue a career in anxiety disorder research was heavily shaped by my experiences with ADAA under Jerilyn’s leadership. Over the years, she articulated eloquently the need to train clinicians, to provide a forum for both basic and clinical researchers, to educate consumers and their loved ones, and to bring all of us together. This rich diversity is what makes ADAA unique. The Annual Conference is a superb legacy of her vision. But if nothing else, Jerilyn loved a good party. In tribute to her spirit, I hope you have a wonderful time, share what you know, take away new ideas, make new acquaintances, and spend a few minutes thinking about how you, too, can make a difference. In considering how best to honor Jerilyn’s legacy, I hope you will join me and become involved in the vital work of ADAA. Welcome! Daniel S. Pine, MD National Institute of Mental Health 2010 Conference Chair

30th Annual Conference | March 4-7, 2010

3

Awards Program | Sponsors 2010 Career Development Travel Award Winners ADAA cultivates the next generation of experts in anxiety disorders by supporting basic and clinical research into the causes, treatments, and cures for anxiety disorders. These awards encourage early career professionals to pursue research careers by supporting the presentation of their research at the ADAA Annual Conference and the annual meeting of either the Association for Behavioral and Cognitive Therapies or the American College of Neuropsychopharmacology. These awards have been given since 1998. Ananda Amstadter, PhD Medical University of South Carolina

Nicole McLaughlin, PhD Butler Hospital/Albert Medical School of Brown University

Kelsey Collimore, MA University of Regina

Robert Pietrzak, PhD, MPH National Center for PTSD/VA Connecticut Healthcare System/Yale School of Medicine

Jesse Cougle, PhD Florida State University

Rebecca Price, MS Rutgers University

Sophie Alice George, PhD University of Michigan Neda Gould, PhD Johns Hopkins University School of Medicine

Casey Schofield, MA Binghamton University Leah Somerville, PhD Sackler Institute of Developmental Psychobiology

Amanda Guyer, PhD University of California, Davis

Jeffrey Strawn, MD Cincinnati Children’s Hospital Medical Center

Anneke Haddad, DPhil University of Oxford Jonathan Burke Kelley, BA University of Miami Miller School of Medicine Anthony King, PhD University of Michigan Medical School

Paul Gerson Unschuld, MD Max Planck Institute of Psychiatry Ilan Wald, MA Tel Aviv University Bethany Wangelin, MS University of Florida

Heide Klumpp, PhD University of Michigan

2010 Donald F. Klein Early Career Investigator Award Winner This award is given for the best original research paper on neurobiology, psychopharmacology, psychosocial treatments, or experimental psychopathology of anxiety and anxiety-related disorders. Donald F. Klein, MD, for whom this award is named, revolutionized psychiatric thinking through his discovery in the early 1960s that imipramine was effective in blocking panic attacks and developing a schema for diagnosing anxiety disorders that is routinely used to this day. This award is supported by ADAA’s journal, Depression and Anxiety, published by Wiley-Blackwell. Greg Hajcak, PhD — first recipient Stony Brook University

ADAA recognizes the support of the following sponsors: Pfizer, Inc. Wiley-Blackwell

4

Anxiety Disorders Association of America

Silent Auction | Social Events 7th Annual Silent Auction Bidding will take place through 2 p.m. on Saturday. Items are on display near Registration and include professional resource books, jewelry, hotel packages, restaurant gift certificates, and other specialty goods and memorabilia. All proceeds support ADAA’s Awards Program and educational outreach efforts, including our campaign to reach more than 16 million college students. Please bid generously! ADAA thanks the following donors for contributing to the success of the ADAA 7th Annual Silent Auction. Air Tran Airways Alies Muskin American Psychiatric Publishing, Inc. Bally Total Fitness Baltimore Marriott Waterfront Baltimore Ravens Baltimore Symphony Orchestra Beth Salcedo, MD Blockbuster Inc. Bloom Putty Carly Sargent Charm City Cakes Commonwealth Digital Office Solutions Costco Wholesale Crystal Gateway Marriott David Hoberman DC United Dick’s Sporting Goods Emotional Armor Founding Farmers Georgia O’Keeffe Museum Welcome Reception Thursday 7:15 pm – 9:30 pm | McCormick & Schmick’s Seafood Restaurant Join us after the Opening Session to celebrate ADAA’s 30th anniversary. Kick off the conference with colleagues and friends while sampling Baltimore’s best food. All registered attendees are welcome. The restaurant is close by. Leave the hotel and turn right to walk along the harbor. Cross the first pedestrian bridge on your left. McCormick & Schmick’s is straight ahead. Breakfast for First-Time Attendees Friday 7:00 am – 8:00 am | Grand Ballroom Salon 5 If you are attending the conference for the first time, learn the inside scoop at a breakfast especially for you. Tribute to Jerilyn Ross Friday 8:30 pm | Laurel Join colleagues for an informal tribute to Jerilyn, and share your stories and memories. Moderated by Terry Keane.

30th Annual Conference | March 4-7, 2010

Guilford Publications Greater Boston Convention and Visitors Bureau Gymboree Hogrefe Publishing Hyatt Regency La Jolla Hyatt Regency Tamaya Resort and Spa M.E. Jewelry Maryland Turf Caterers New Harbinger Publications New Orleans Marriott Omni Hotels Oxford University Press Pat Harvey, LCSW-C, ACSW Philip Muskin, MD Sally Winston, PsyD San Diego Convention and Visitors Bureau Santa Fe Convention and Visitors Bureau Stress Free Kids Walt Disney World Washington Capitols Whole Foods Market

Night at the Aquarium Saturday 7:00 pm – 10:00 pm The National Aquarium in Baltimore will come to life after hours just for us. Mingle with colleagues and view more than 200 aquatic species as you tour the internationally acclaimed aquarium. Enjoy a three-course dinner buffet overlooking the water, then walk with the sharks as you wind around the main tank to the music of local band Blues Therapy. Tickets are required and can be purchased at Registration until 5 p.m. Friday. Price is $60 per person for adults and children. The aquarium is a short walk from the hotel.

5

Thursday, March 4 All conference attendees must be registered. Badges are required for admission to all sessions, meals, and receptions. Please wear your badge during the conference. 8:00 am – 6:00 pm | Registration 10:00 am – 1:00 pm | Kent 209C Talking to Anxiety: The Whys and Hows Reid Wilson, PhD, Anxiety Disorders Treatment Center In this workshop, participants will learn how to offer clients a simple cognitive schema that counters attentional bias toward threat. By learning to talk to anxiety, and to themselves, clients purposely seek out discomfort and uncertainty as their ticket to freedom from crippling fear. By offering the patient such paradoxical responses to the moves made by anxiety disorders, they can begin to change the course of the therapeutic game. 1:00 pm – 3:00 pm | Essex 226C Anxiety Disorders 101 Sally Winston, PsyD, Anxiety & Stress Disorders Institute of Maryland, and Golda Ginsburg, PhD, Johns Hopkins University School of Medicine An introduction to the field of anxiety disorders, this course is appropriate for beginning clinicians and seasoned practitioners. Drs. Winston and Ginsburg will provide basic information about the phenomenology, symptoms, and differential diagnosis of each of the anxiety disorders. Evidence-based treatments will be described in detail. The first half will focus on adults and the second on children. This will be a lively clinically focused presentation. 1:30 pm – 3:00 pm | Kent 4C Master Clinician: Implementing Prolonged Exposure for PTSD: Optimizing Outcomes Edna Foa, PhD, University of Pennsylvania Prolonged exposure therapy (PE), a cognitivebehavioral therapy using both in-vivo and imaginal exposure, has been shown to be effective for various types of traumas and for men and women. Dr. Foa will describe the major components of PE and will demonstrate how these components are delivered via role-play with a patient (volunteer) who developed chronic PTSD after rape. She will also discuss common difficulties that may arise during PE therapy.

6

1:30 pm – 3:00 pm | Laurel CD 3C Master Clinician: Discontinuation of Medication Michael Otto, PhD, Boston University Antidepressant and benzodiazepine (BZ) medications have demonstrated efficacy across a range of anxiety disorders. However, the discontinuation of these medications is associated with high rates of relapse. In this workshop, the rationale and elements of exposurebased CBT for medication discontinuation will be reviewed and exemplified. Strategies for withdrawal of sleep medications and BZ use will also be reviewed and discussed. 3:30 pm – 5:00 pm | Kent 6C Master Clinician: Acceptance and Commitment Therapy (ACT) as Treatment for Anxiety Disorders Michael Twohig, PhD, Utah State University Dr. Twohig will discuss, teach, and demonstrate how to incorporate acceptance and commitment therapy (ACT) into one’s clinical work. Participants will learn what psychological processes are targeted in ACT and how to detect them in session. Participants will also learn how to target these processes while using ACT alone and how to incorporate ACT into their existing work, including traditional exposure therapy methods. 3:30 pm – 5:00 pm | Essex 5C Master Clinician: Complex Cases: When Things Go Wrong Sally Winston, PsyD, Anxiety & Stress Disorders Institute of Maryland Few patients have pure forms of an anxiety disorder free of comorbidities and relevant psychosocial issues. Therapists may intend to deliver protocol-based, empirically derived treatments and find themselves ineffective, diverted, and falling back on clinical intuitions. Dr. Winston will share experiences of complex cases — ones that did not go as planned, ones that did not get better — and discuss how to handle unpredicted jogs in therapy work.

Anxiety Disorders Association of America

Thursday, March 4 | Friday, March 5 4:00 pm – 5:00 pm | Laurel CD 224R Early Career Researchers on Applying for Grants Michael Kozak, PhD, National Institute of Mental Health An application for NIH research support must proceed through many steps. Dr. Kozak will present an overview of the administrative structure of NIMH and its research funding mechanisms and priorities. Factors that affect the likelihood of funding will be considered, including idea development, consultation with NIH staff, application planning and development, and institutional involvement. Elements of the review process will also be considered. 5:00 pm – 7:00 pm | Harborside Ballroom Opening Session Welcome Jerrold Rosenbaum, MD, Chair, ADAA Board of Directors Conference Overview Daniel S. Pine, MD, 2010 Conference Chair Keynote Speaker Trisha Meili, author of I Am the Central Park Jogger Tribute to Jerilyn Ross Robert DuPont, MD Sally Winston, PsyD Dennis Charney, MD Ron Cohen 7:15 pm – 9:30 pm | McCormick & Schmick’s Seafood Restaurant Welcome Reception Join us after the Opening Session to celebrate ADAA’s 30th anniversary. Kick off the conference with colleagues and friends while sampling Baltimore’s best food. All registered attendees are welcome. Please wear your badge. A cash bar will be available. The restaurant is close by. Leave the hotel and turn right to walk along the harbor. Cross the first pedestrian bridge on your left. McCormick & Schmick’s is straight ahead.

FRIDAY, MARCH 5 7:30 am – 5:00 pm | Registration 7:00 am – 8:00 am | Grand Foyer West Continental Breakfast First-time attendees, meet in Grand Ballroom Salon 5 for breakfast and to get the inside scoop on the conference. 7:00 am – 8:00 am | Waterview Ballroom Depression and Anxiety Editorial Board Meeting 8:00 am – 9:15 am | Harborside Ballroom General Session: 220C/R How Science Informs Treatment ADAA Awards Program Presentation David Barlow, PhD, Boston University; Donald Klein, MD, Columbia University Medical Center 9:30 am – 10:00 am | Grand Ballroom Salon 2 40R Does Acute Nicotine Use or Withdrawal Promote Panicky Symptoms? Some Surprising Findings From Biological Challenge Studies Kenneth Abrams, PhD, Carleton College 9:30 am – 10:00 am | Laurel CD 69R Neurobiology of Early Life Stress: Brain, Body, and Mind Jeremy Coplan, SUNY Downstate Medical Center 9:30 am – 10:00 am | Grand Ballroom Salon 4 121C Using Psychodrama and Visualization as an Exposure Tool With Adults and Children Myron Downing, PhD, LMFT, 2GetHelp Wellness Center 9:30 am – 10:30 am | James 102C The Fatal Addiction to Plastic Surgery: Diagnosing and Treating BDD Successfully for a Lifetime Eda Gorbis, PhD, Westwood Institute of Anxiety Disorders 9:30 am – 10:30 am | Iron 118C Treatment of Comorbid ADHD in Adults With Anxiety Disorders Wendy Freeman, PhD, and Michael Van Ameringen, MD, FRCPC, McMaster University NOTE | The C and R after session numbers refer to Clinical and Research sessions.

30th Annual Conference | March 4-7, 2010

7

Friday, March 5 9:30 am – 11:00 am | Grand Ballroom Salon 3 196C Exposure and Response Prevention for OCD: What It Is and How to Do It Katherine Muller, PsyD, Montefiore Medical Center/Albert Einstein College of Medicine 9:30 am – 11:00 am | Grand Ballroom Salon 1 225C What Clinicians Need to Know About Eating Disorders Cynthia Bulik, PhD, University of North Carolina at Chapel Hill 9:30 am – 11:30 am | Dover 141R Advances in Social Anxiety Theory, Disorder Development, and the Latent Structure Debate Chair: R. Nicholas Carleton, MA, University of Regina A Revision to the Rapee and Heimberg Cognitive-Behavioral Model for Social Anxiety Disorder Faith Brozovich, MA, Temple University Social Anxiety Disorder Across the Lifespan Deborah Beidel, PhD, University of Central Florida Social Anxiety Disorder and PTSD: The Impact of Social Events Perceived as Traumatic R. Nicholas Carleton, MA, University of Regina Carving Social Anxiety Disorder at Its Joints: Evidence Supporting a Taxonic Structure of Social Anxiety Disorder Justin Weeks, PhD, Ohio University Discussant: Bradley Riemann, PhD, Rogers Memorial Hospital 9:30 am – 11:30 am | Kent 159C Implementation of Evidence-Based PTSD Treatments in the Veterans Health Administration Chair: Josef Ruzek, PhD, National Center for PTSD Disseminating Prolonged Exposure Therapy (PE) for PTSD in the VA: Description of PE and the Method of its Dissemination Edna Foa, PhD, University of Pennsylvania Dissemination of Prolonged Exposure Therapy in VHA: Evaluation of Training and Lessons Learned Afsoon Eftekhari, PhD, National Center for PTSD Disseminating Cognitive-Processing Therapy in VA Patricia Resick, PhD, National Center for PTSD

8

Phase 3: Decentralizing Cognitive-Processing Therapy Into VA Kathleen Chard, PhD, Cincinnati VA Medical Center Discussant: Bradley Karlin, PhD, U.S. Department of Veterans Affairs 9:30 am – 11:30 am | Laurel AB 169R The CALM Study: Initial Findings Chair: Peter Roy-Byrne, MD, University of Washington Coordinated Anxiety Learning and Management (CALM) for Primary Care Anxiety Peter Roy-Byrne, MD, University of Washington Coordinated Anxiety Learning and Management (CALM) in Primary Care: Outcomes for Panic Disorder, Social Anxiety Disorder, Generalized Anxiety Disorder, and Posttraumatic Stress Disorder Raphael Rose, PhD, University of California, Los Angeles Does CBT Combined With Medication Management Improve Outcomes in CALM? Murray Stein, MD, MPH, University of California, San Diego Does a Quality Improvement Intervention for Anxiety Disorders Result in Differential Outcomes for Economically Disadvantaged Patients? Cathy Sherbourne, PhD, RAND Corporation Implementing Collaborative Care for Anxiety Disorders in Primary Care Clinics Greer Sullivan, MD, MSPH, University of Arkansas for Medical Sciences 9:30 am – 11:30 am | Essex 197C Health Anxiety in Kids: Treating Anxious Children and Overprotective Parents Kevin Gyoerkoe, PsyD; Seoka Salstrom, PhD; Amanda Holly, PhD, Anxiety and Agoraphobia Treatment Center 10:00 am – 12:00 pm | Laurel CD 165R Multimethod Approaches to Understanding the Cognitive Neuroscience of Anxiety Across the Lifespan Chairs: Koraly Perez-Edgar, PhD, George Mason University, and Amanda Guyer, PhD, University of California, Davis Selective Attention to Emotion as a Mechanism in the Emergence of Anxiety Koraly Perez-Edgar, PhD, George Mason University Anxiety Disorders Association of America

Friday, March 5 Neural Functional Alterations During Reward Anticipation in Anxious Adolescents Amanda Guyer, PhD, University of California, Davis Examination of Amygdala-Based Circuits in Pediatric Anxiety Disorders Using Resting-State MRI Amy Roy, PhD, New York University Fear-Conditioning Abnormalities in Anxiety: The Role of Stimulus Generalization and Inhibitory Control Anneke Haddad, DPhil, University of Oxford Discussant: Erin Tone, PhD, Georgia State University 10:00 am – 12:00 pm | Grand Ballroom Salon 2 176R Substance Abuse Risk Among Those With Anxiety: Application of Laboratory Findings to Clinical Practice Chairs: Julia Buckner, PhD, and Jose Silgado, BS, Louisiana State University Alcohol-Outcome Expectancies and State Social Anxiety: Predicting Urge and Likelihood to Drink in a Social Situation Amy Bacon, MA, University of Arkansas Understanding Marijuana Use Vulnerability Among Those With Social Anxiety Disorder: Marijuana Craving During a Public Speaking Challenge Jose Silgado, BS, Louisiana State University An Evaluation of Pain-Related Anxiety Among Daily Cigarette Smokers in Terms of Negative and Positive Reinforcement Smoking-Outcome Expectancies Adam Gonzalez, BA, University of Vermont Immediate Antecedents of Marijuana Use in the Natural Environment Among Those With Social Anxiety Disorder: An Analysis From Ecological Momentary Assessment Julia Buckner, PhD, Louisiana State University Discussant: Sherry Stewart, PhD, Dalhousie University 10:00 am – 12:00 pm | Grand Ballroom Salon 4 191C Depersonalization: Clinical Features and Treatment Approaches Fugen Neziroglu, PhD, and Katharine Donnelly, MA, Bio-Behavioral Institute

10:30 am – 12:00 pm | James 185C Adapting Cognitive-Behavioral Therapy for Anxious Children for Nonacademic Settings Katharina Manassis, MD, FRCPC, University of Toronto 10:30 am – 12:00 pm | Iron 222C What Clinicians Need to Know About Antidepressants and Suicide Kelly Posner, PhD, Columbia University Medical Center/New York State Psychiatric Institute 11:00 am – 12:00 pm | Grand Ballroom Salon 1 37C Dilemmas in the Treatment of Patients With Anorexia Nervosa and Comorbid Obsessive-Compulsive Disorder Kim Rockwell-Evans, PhD, Private Practice 11:00 am – 12:00 pm | Grand Ballroom Salon 3 202C Intensive Treatment for Severe OCD: How Far Do You Go? Eda Gorbis, PhD, LMFT, Westwood Institute of Anxiety Disorders; Jenny Yip, PsyD, Renewed Freedom Treatment Center for Rapid Anxiety Relief 11:30 am – 12:00 pm | Laurel AB Donald F. Klein Early Career Investigator Award Winning Paper: 228R Distinct Electrocortical and Behavioral Evidence for Increased Attention to Threat in Generalized Anxiety Disorder Greg Hajcak, PhD, and Annmarie MacNamara, BA, Stony Brook University 11:30 am – 12:00 pm | Kent 21C Anxiety in College Populations: A Special Emphasis on PTSD and Returning-Student Military Veterans Theresa Souza, MS, and Nishani Samaraweera, MA, Western Michigan University 11:30 am – 12:00 pm | Essex 65C Loving Someone With an Anxiety Disorder: The Role of Family in Treatment Karen Landsman, PhD, and Kathleen Rupertus, PsyD, Private Practice

NOTE | The C and R after session numbers refer to Clinical and Research sessions.

30th Annual Conference | March 4-7, 2010

9

Friday, March 5 12:00 pm – 1:15 pm | Harborside Ballroom Lunch and General Session 9C/R DSM V: Its Impact on Practice and Research Chair: Jonathan Abramowitz, PhD, University of North Carolina at Chapel Hill Katharine Phillips, MD, Alpert Medical School of Brown University ; Dan Stein, MD, University of Stellenbosch; Roberto Lewis-Fernández, MD, New York State Psychiatric Institute/Columbia University; Simon Rego, PsyD, Montefiore Medical Center; Reid Wilson, PhD, Anxiety Disorders Treatment Center; Bradley Riemann, PhD, Rogers Memorial Hospital Lunch is included for all attendees. 1:30 pm – 2:30 pm | Grand Ballroom Salon 3 19R Anxiety in Anorexia Nervosa: Empirical Support for a Theoretical Model and Treatment Implications Joanna Steinglass, MD, Columbia University Medical Center 1:30 pm – 2:30 pm | Grand Ballroom Salon 2 31C Clinical Practice With Older Adults Who Hoard: Matching Treatment and Intervention Strategies With a Particular Client Profile Elspeth Bell, PhD, Behavior Therapy Center of Greater Washington 1:30 pm – 3:00 pm | Grand Ballroom Salon 4 158C Identifying and Treating Generalized Anxiety Disorder Through the Use of GADSpecific Safety Behaviors: Rationale and Clinical Applications Melisa Robichaud, PhD, Vancouver CBT Centre, and Heather Baker, MA, University of British Columbia 1:30 pm – 3:00 pm | James 186C Anxiety Disorders and Chronic Pain: An Update for Non-Pain Specialists Ricks Warren, PhD, University of Michigan 1:30 pm – 3:00 pm | Iron 208C SOS Sister Circles: CBT Anxiety Intervention in the African American Tradition Angela Neal-Barnett, PhD; Margaret Ralston Payne, MA; Masheena Murray, MA, Kent State University

1:30 pm – 3:00pm | Laurel CD 168R OCD Research Collaborative Association (ORCA): Evaluating the Effectiveness of Residential and Intensive Outpatient Treatment Programs in Adolescents and Adults Chairs: Bradley Riemann, PhD, Rogers Memorial Hospital, and Shawn Cahill, PhD, University of Wisconsin, Milwaukee Treatment of OCD at Rogers Memorial Hospital: Description of the Programs and Patient Characteristics at Admission Bradley Riemann, PhD, Rogers Memorial Hospital Residential and Intensive Outpatient Treatment of Adult OCD: An Investigation of Treatment Response, Mediators, and Moderators of Treatment Outcome and Comparison With Efficacy Trials Shawn Cahill, PhD, University of Wisconsin, Milwaukee Cognitive-Behavioral Therapy in Adolescents: Examining the Effectiveness of Residential and Intensive Outpatient Treatment Martin Franklin, PhD, University of Pennsylvania School of Medicine Comorbid OCD and Eating Disorders: Results From a Specialty Residential Program Chad Wetterneck, PhD, University of Houston, Clear Lake Discussant: Thröstur Björgvinsson, PhD, Houston OCD Program 1:30 pm – 3:00 pm | Laurel AB 172R Reduce Limitations From Anxiety: Main Outcomes From the RELAX Trial of Telephone-Delivered Collaborative Care for Panic and Generalized Anxiety Disorder in Primary Care Chair: Bruce Rollman, MD, MPH, University of Pittsburgh The Relax Trial: Main Outcomes Bruce Rollman, MD, MPH, University of Pittsburgh The RELAX Trial Enrollment Strategy: Electronic Physician Prompts Versus Traditional Waitroom Case-Finding Strategy Bruce Rollman, MD, MPH, University of Pittsburgh The RELAX Trial Intervention Bea Herbeck Belnap, Dr Biol Hum, University of Pittsburgh Discussant: Murray Stein, MD, MPH, University of California, San Diego

10

Anxiety Disorders Association of America

Friday, March 5 1:30 pm – 3:00 pm | Grand Ballroom Salon 1 221C What Clinicians Need to Know About Bipolar Disorder in Children Ellen Leibenluft, MD, National Institute of Mental Health 1:30 pm – 3:30 pm | Dover 183C Acceptance and Commitment Therapy Principles and Techniques for ObsessiveCompulsive Spectrum Disorders Katharine Donnelly, MA, and Fugen Neziroglu, PhD, Bio-Behavioral Institute 1:30 pm – 3:30 pm | Essex 201C Innovative Procedures for Behavioral Experiments and Exposures With Anxious Youth Robert Friedberg, PhD, ABPP, Penn State Milton S. Hershey Medical Center/College of Medicine 1:30 pm – 3:30 pm | Kent 215C Treatment of Social Anxiety Disorder and Social Isolation: Helping Clients to Improve Friendships and Social Life John Walker, PhD, and Patricia Furer, PhD, University of Manitoba 2:30 pm – 5:30 pm | Harborside Ballroom 8R SCIENTIFIC RESEARCH SYMPOSIUM The Cost of War: Understanding the Science of PTSD Chairs: Terence Keane, PhD, VA Boston Healthcare System/National Center for PTSD/Boston University School of Medicine, and Kerry Ressler, MD, PhD, Emory University Neural Circuitry Mediating Fear and Its Inhibition in Animals Gregory Quirk, PhD, University of Puerto Rico School of Medicine Neural Circuitry Mediating Fear and Its Inhibition in Humans Paul Whalen, PhD, Dartmouth College Functional Brain Abnormalities in PTSD: Results From Neuroimaging Lisa Shin, PhD, Tufts University Genetics of PTSD: Fear Conditioning as a Model for Future Research Karestan Koenen, PhD, Harvard School of Public Health Recent Advances in Psychological Health Care and Programs in the Department of Defense Sonja V. Batten, PhD, Defense Centers of Excellence for Psychological Health and Traumatic Brain Injury 30th Annual Conference | March 4-7, 2010

3:30 pm – 4:30 pm | Laurel AB Anxiety Treatment in Primary Care 29R CALM Across the Lifespan: Patient Age and Proficiency of Use of Computer-Assisted Cognitive-Behavioral Therapy for Anxiety Disorders in Primary Care Katharina Kircanski, MA, University of California, Los Angeles 30R Characteristics and Predictors of Social Anxiety Disorder Course in a Longitudinal Study of Primary Care Patients Courtney Beard, PhD, Alpert Medical School of Brown University 3:30 pm – 4:30 pm | Laurel CD Research on OCD 94R Should OCD Be Considered an Anxiety Disorder, and What, if Any, Are OCD-Related Conditions? O. Joseph Bienvenu, MD, Johns Hopkins University 91R Recent Findings on the Genetics of OCD Jack Samuels, PhD, Johns Hopkins University School of Medicine 3:30 pm – 5:00 pm | Iron Anxiety in African Americans 53R Generalized Anxiety Disorder in African Americans: Race, Gender, and Maternal Education Level as Predictors of GAD Correlates Elena Wright, BA, Yale University 33R Correlates of Anxiety Sensitivity Among African American Youth Living in Public Housing Nicole Goodman, BS, Howard University 24R Assessing the Moderating Effects of Anxiety Sensitivity on Antisocial Behavior Among Urban African American Youth Nicole Goodman, BS, Howard University 3:30 pm – 5:00 pm | Grand Ballroom Salon 1 149C Beyond Sadness and Worry: How Much Is Too Much in Pediatric and Adult Patients With Medical Illness? Philip Muskin, MD, Columbia University Medical Center, and Maryland Pao, MD, National Institute of Mental Health

NOTE | The C and R after session numbers refer to Clinical and Research sessions.

11

Friday, March 5 3:30 pm – 5:00 pm | Dover 178C The Ethics of Exposure: Is There Such a Thing as Too Far? Chair: Patrick McGrath, PhD, Alexian Brothers Behavioral Health Hospital

3:30 pm – 5:30 pm | Grand Ballroom Salon 3 192C Eating and Anxiety: Novel Treatments to Address Comorbid Diagnoses and Coexisting Symptoms Joanna Steinglass, MD, Columbia University Medical Center, and Bradley Riemann, PhD, Rogers Memorial Hospital

Thursday, March 4 | Preconference Institute

Thröstur Björgvinsson, PhD, Houston OCD Program; Jonathan Abramowitz, PhD, University of North Carolina at Chapel Hill; Stephen Whiteside, PhD, Mayo Clinic; Denise Stack, MA, McLean Hospital 3:30 pm – 5:30 pm | Essex 170R Prevention of Anxiety Disorders in Youth: Addressing New Populations and Perceived Barriers to Implementation Chair: Emily Laird, BA, University of Miami Family-Based Prevention of Anxiety Disorders in Youth Golda Ginsburg, PhD, Johns Hopkins University School of Medicine Cultural Adaptations for Anxious Youth in School Settings Lynn Miller, PhD, University of British Columbia Emotion Detectives: A Universal Prevention for Anxiety and Depression Emily Laird, BA, University of Miami Building Social and Emotional Skills in Mexican Primary School Children: An Evaluation of the FRIENDS Program Julia Gallegos, PhD, Universidad de Monterrey Levels of Perceived Stigma and Program Satisfaction Among Children Undergoing School-Based Early Intervention for Anxiety and Depression Ronald Rapee, PhD, Macquarie University Discussant: Anne Marie Albano, PhD, Columbia University 3:30 pm – 5:30 pm | Grand Ballroom Salon 4 184C Acceptance-Based Behavioral Therapy for Generalized Anxiety and Comorbid Disorders Lizabeth Roemer, PhD, University of Massachusetts, Boston

12

4:30 pm – 5:30 pm | Kent 76C Older Adults With Health Anxiety Related to Cognitive Changes: Diagnostic Issues and Treatment Strategies Brian Schmaus, PhD, Anxiety and Agoraphobia Treatment Center, and Sherri Hayden, PhD, University of British Columbia 5:00 pm – 5:30 pm | Laurel CD 20C Anxiety in Cancer Patients: Prevalence and Management Catherine Mancini, MD, FRCPC, and Wendy Freeman, PhD, McMaster University 5:00 pm – 5:30 pm | Iron 51R Fears in Indian Children and Adolescents: A Cross-Cultural Perspective Jaee Bodas, PhD, Virginia Commonwealth University 5:30 pm – 6:30 pm | Boardroom Clinical Advisory Board Meeting 5:30 pm – 7:00 pm | Grand Ballroom Salons 5-10 New Research Poster Session & Case Presentations The list of poster titles and authors begins on page 32. 8:30 pm | Laurel Remembering Jerilyn Ross Join colleagues for an informal tribute to Jerilyn, and share your stories and memories. Moderated by Terry Keane. See page 29 for a tribute to Jerilyn.

Anxiety Disorders Association of America

Saturday, March 6 SATURDAY, MARCH 6 7:30 am – 5:00 pm | Registraton 7:30 am – 9:00 am | Harborside Foyer Continental Breakfast 7:30 am – 9:00 am | Waterview Ballroom Scientific Advisory Board Meeting 8:00 am – 9:00 am | Grand Ballroom Salon 7 12C Understanding and Treating “Homosexual” OCD Lisa Levine, PsyD, Behavior Therapy Center of Greater Washington 8:00 am – 9:00 am | Dover Papers on Attention Bias 26R Attentional Bias as an Endophenotype for Anxiety in Pediatric Samples: Insights and Contradictions From the Literature Katherine O’Donnell, BA, McGill University 25R Attention Bias Modification (ABM): A Novel Treatment for Anxiety Disorders Yair Bar-Haim, PhD, Tel Aviv University 8:00 am – 9:00 am | Grand Ballroom Salon 9 35C Cultivating Treatment Readiness in Anxious Children and Adolescents Aureen Wagner, PhD, University of Rochester 8:00 am – 9:00 am | Galena 54R Group CBT for Social Anxiety Disorder: How Can We Develop It Further? Andri Bjornsson, PhD, Brown University 8:00 am – 9:00 am | James 86R Prenatal PTSD: From Determining the Impact to Piloting the Survivor Moms’ Companion Intervention Julia Seng, PhD, University of Michigan 8:00 am – 9:00 am | Kent 114C Trauma Psychology: What the Anxiety Disorders Specialist Needs to Know Lisa Rocchio, PhD, Private Practice 8:00 am – 9:00 am | Essex 115C Treating Test Anxiety in Students and Performance Anxiety in Athletes Robert Schachter, PhD, EdD, Mount Sinai School of Medicine

30th Annual Conference | March 4-7, 2010

8:00 am – 9:00 am | Grand Ballroom Salon 8 130C When Helping Hurts: Overaccommodation of the Adult Child Noah Weintraub, PsyD, Behavior Therapy Center of Greater Washington 8:00 am – 9:00 am | Laurel AB 162C Integrative Approaches in the Treatment of Fear of Flying Chairs: Shreya Patel Hessler, PsyD, Private Practice, and Stephnie Thomas, LPC, MS, Anxiety & Stress Disorders Institute of Maryland Thirty Years of Fear of Flying Consultations: No, It’s Not Usually a “Simple Phobia” and Yes, Turbulence is Often Existential as Well as Phobic Steve Shearer, PhD, Anxiety & Stress Disorders Institute of Maryland Behavior Analysis and In-Vivo Exposure for Fear of Flying Clients With Comorbid Anxiety and Intellectual Disabilities Shreya Patel Hessler, PsyD, Private Practice More Than Psychotherapy: Practical Lessons Learned Out of the Office While Treating Clients With a Fear of Flying Stephnie Thomas, LPC, MS, Anxiety & Stress Disorders Institute of Maryland Development of and Potential Generalizability of a Three-Session, In Vivo Fear of Flying Class Robert Clark, MS, Uniformed Services University of the Health Sciences Discussant: Steve Shearer, PhD, Anxiety & Stress Disorders Institute of Maryland 8:00 am – 9:00 am | Laurel CD 174R Sleep Problems in Children With Anxiety Disorders: Who and What Should We Be Treating? Pre-Sleep Arousal and Sleep Problems of Anxiety-Disordered Youth Candice Alfano, PhD, Children’s National Medical Center/George Washington University School of Medicine Sleep-Related Problems in Pediatric OCD Nicole Caporino, MA, University of South Florida Hush Child, Let Mommy Sleep! Do Sleep Problems Improve With CBT for Childhood Anxiety? Armando Piña, PhD, Arizona State University NOTE | The C and R after session numbers refer to Clinical and Research sessions.

13

Saturday, March 6 8:00 am – 9:00 am | Grand Ballroom Salon 3 210C The “How To” of Habit Reversal Training (HRT) for Body-Focused Repetitive Disorders Simon Rego, PsyD, ABPP, Montefiore Medical Center 9:00 am – 10:15 am | Harborside Ballroom General Session: 7C/R Anxiety Across the Lifespan Anxiety Disorders in Children Ronald Rapee, PhD, Macquarie University Anxiety Disorders in Women Margaret Altemus, MD, Weill Cornell Medical College Older Adults and Anxiety Disorders Melinda Stanley, PhD, Baylor College of Medicine 10:00 am – 12:00 pm | Grand Ballroom Salon 1, 2 Consumer Program: When Anxiety Takes Over Your Life

10:30 am – 11:30 am | Iron 83C Paruresis, or Shy Bladder Syndrome: An Update From the Field Steven Soifer, PhD, University of Maryland School of Social Work 10:30 am – 11:30 am | Kent 116R Treating PTSD in Children Exposed to Domestic Violence: Initial RCT Findings Judith Cohen, MD, Allegheny General Hospital 10:30 am – 12:00 pm | Grand Ballroom Salon 3 150C Breath-Body-Mind Practices for Treatment of Anxiety Disorders The Neurophysiology of Anxiety Disorders and the Effects of Specific Breath and Meditation Practices on the Stress-Response Systems Richard Brown, MD, Columbia University College of Physicians and Surgeons

10:00 am – 2:00 pm | Boardroom Board of Directors Meeting

Breath-Body-Mind Practices for Treatment of Anxiety Disorders Patricia Gerbarg, MD, New York Medical College

10:30 am – 11:00 am | Galena 16R Amygdala Activation as a Predictor of CBT Treatment Outcome in Social Phobia Erin Tone, PhD, Georgia State University

Multicomponent Breath-Body-Mind Programs as Adjunctive Treatment in Generalized Anxiety Disorders Martin Katzman, MD, FRCPC, START Clinic for Mood and Anxiety Disorders

10:30 am – 11:00 am | Laurel AB 79R Panic Attacks in Generalized Anxiety Disorder Michael Van Ameringen, MD, FRCPC; Catherine Mancini, MD, FRCPC; William Simpson, BSc; Beth Patterson, BScN, BEd, McMaster University Medical Center 10:30 am – 11:00 am | James 133C Implementation of a Web-Based Mental Health Screener at a Public State College Andrew Berger, PhD, Private Practice 10:30 am – 11:30 am | Grand Ballroom Salon 7 11C Extreme Exposure and Response Prevention for OCD: How to Help Sufferers Do It and Be Comfortable at the Same Time Jonathan Grayson, PhD, Anxiety & OCD Treatment Center of Philadelphia

Breath-Body-Mind Program for Recovery From Effects of the 2001 September 11 World Trade Center Terrorist Attacks Martin Katzman, MD, FRCPC, START Clinic for Mood and Anxiety Disorders 10:30 am – 12:00 pm | Laurel CD 167R Network Abnormalities Inform Clinical Symptoms in PTSD Chair: Lisa Shin, PhD, Tufts University Generalization of Conditioned Fear as a Pathogenic Marker of PTSD Shmuel Lissek, PhD, National Institute of Mental Health Dorsal Anterior Cingulate Function in PTSD Lisa Shin, PhD, Tufts University “Default Network” Abnormalities in PTSD: An fMRI Investigation Ruth Lanius, MD, PhD, University of Western Ontario PET Imaging Unravels the Biological Heterogeneity of PTSD Alexander Neumeister, MD, Yale School of Medicine

14

Anxiety Disorders Association of America

Saturday, March 6 10:30 am – 12:00 pm | Dover 179R The Role of Psychophysiology in the Understanding and Assessment of Childhood Anxiety Disorders Chairs: Thomas Ollendick, PhD, and Kristy Benoit, MS, Virginia Tech Psychophysiological Reactivity and Regulation Across Different Child Anxiety Disorders Abbe Marrs Garcia, PhD, Alpert Medical School of Brown University The Tripartite Model of Fear in Phobic Children: Assessing Concordance and Discordance Using the Behavioral Approach Test Kristy Benoit, MS, Virginia Tech Social Anxiety and the Coupling of Frontal Brain Oscillations Vladimir Miskovic, BA, McMaster University

The Perils of Everything: Patient Paralyzed by Fear of Harming Objects, Animals, and People Thröstur Björgvinsson, PhD, Houston OCD Program 10:30 am – 12:30 pm | Grand Ballroom Salon 8 175R Social Anxiety Disorder: Assessing the Role of Social Skill in Intervention Planning and Outcome Chair: Deborah Beidel, PhD, University of Central Florida The Presence of Social Skill Deficits Among Adults with Social Anxiety Disorder Deborah Beidel, PhD, University of Central Florida

Now You See It, Now You Don’t: Where Is Respiration in Child Heart Rate Variability? Ben Allen, MS, Virginia Tech

Mediators and Moderators of Outcome in the Behavioral Treatment of Childhood Social Phobia Candice Alfano, PhD, Children’s National Medical Center/George Washington University School of Medicine

Infants’ Reactivity to Psychosocial Challenge: Evaluation of an Ambulatory Monitoring Technique for Assessments of Cardiorespiratory Activity Thomas Ritz, PhD, Southern Methodist University

Do Pharmacological and Behavioral Interventions Differentially Affect Treatment Outcome for Children With Social Phobia? Lindsay Scharfstein, MS, University of Central Florida

Discussant: Alicia Meuret, PhD, Southern Methodist University 10:30 am – 12:30 pm | Grand Ballroom Salon 6 142C Anxiety Disorder Rounds: A Focus on OCD Chair: Robert Ackerman, MSW, SUNY Downstate Medical Center Overcoming Orthodox Scrupulosity in a Young Woman: The Use of Exposure, Cognitive Therapy, and Chabad Lubavitch to Date and Marry Karen Cassiday, PhD, Anxiety & Agoraphobia Treatment Center The Girl Who Couldn’t Stop Moving Charles Mansueto, PhD, Behavior Therapy Center of Greater Washington Jack Gets in the Door: A Session Video of Novel Techniques in the Treatment of OCD of a Violent Abhorrent Nature Robert Ackerman, MSW, SUNY Downstate Medical Center Help! My Five-Year-Old Has Every Symptom in the Book! Aureen Wagner, PhD, University of Rochester

30th Annual Conference | March 4-7, 2010

How “Global” Are Clinicians’ Ratings of Socially Anxious Children’s Improvements in Global Functioning? Andres De Los Reyes, PhD, University of Maryland, College Park 10:30 am – 12:30 pm | Essex 193C Evidence-Based Practical Strategies for the Treatment of Anxiety-Related School Refusal Jonathan Dalton, PhD, Behavior Therapy Center of Greater Washington 10:30 am – 12:30 pm | Grand Ballroom Salon 9 211C The Healing Power of Children’s Imagination: How to Transform Stress and Anxiety Into Joy and Success Charlotte Reznick, PhD, University of California, Los Angeles 11:00 am – 11:30 am | Galena 58C How Can Neuroimaging Research Inform Treatment of Anxiety Disorders? Erin Tone, PhD, Georgia State University NOTE | The C and R after session numbers refer to Clinical and Research sessions.

15

Saturday, March 6 11:00 am – 12:00 pm | James 22C Application of Dialectical Behavior Therapy to OC Spectrum Disorders Jennifer Lafferty O’Connor, PhD, Remuda Ranch 11:30 am – 12:00 pm | Kent 68R Neural Systems Dysfunction During Anticipation in Women With Posttraumatic Stress Disorder Related to Intimate Partner Violence Robin Aupperle, PhD, VA San Diego Healthcare System/University of California, San Diego 11:30 am – 12:30 pm | Galena 144R Anxiety, Neuroimaging, and the Genome A Twin Imaging Study of Generalized Anxiety Disorder John Hettema, MD, PhD, Virginia Commonwealth University Genetic Studies of Anxiety-Related Temperament and Brain Phenotypes Jordan Smoller, MD, ScD, Massachusetts General Hospital Genetic Association Studies of Anxious Depression Gonzalo Laje, MD, MHSc, National Institute of Mental Health 11:00 am – 12:30 pm | Laurel AB 161R Improving Understanding of Generalized Anxiety Disorder: What Can We Learn From Epidemiological, Experimental, and Clinical Studies? Chairs: Katja Beesdo-Baum, PhD, and Sabine Schoenfeld, PhD, Technische Universitaet Dresden Insights Into the Diagnosis of GAD From a Developmental, Epidemiological Perspective Katja Beesdo-Baum, PhD, Technische Universitaet Dresden Experimental Investigation of an EmotionDysregulation Model of GAD Sabine Schoenfeld, PhD, Technische Universitaet Dresden The Neuroanatomy of Anticipatory and Regulatory Dysfunction in GAD Jack Nitschke, PhD, University of Wisconsin, Madison Worried Sleep: 24-Hour Monitoring in Highand Low-Worriers Sigrun Doberenz, Stanford University/VA Palo Alto Health Care System

16

The Effectiveness of Cognitive-Behavioral Treatment Elements for GAD Jürgen Hoyer, PhD, Technische Universitaet Dresden Discussant: Daniel S. Pine, MD, National Institute of Mental Health 11:30 am – 12:30 pm | Iron 189C Cognitive-Behavioral Treatment for Death Anxiety Patricia Furer, PhD, and John Walker, PhD, University of Manitoba 11:30 am – 12:30 pm | Grand Ballroom Salon 7 190C DBT Skills to Help Children With Emotion Dysregulation and Their Parents Pat Harvey, LCSW-C, ACSW, Private Practice 12:00 pm – 12:30 pm | Kent 14R Abnormal Metabolic Activation of Fear and Arousal Responses as a Model of Vulnerability to Panic Disorder Richard Maddock, MD, University of California, Davis 12:00 pm – 12:30 pm | Grand Ballroom Salon 3 66C Mindfulness and Acceptance Strategies for Anxious Children and Parents Chris McCurry, PhD, Associates in Behavior and Child Development, Inc. 12:00 pm – 12:30 pm | Laurel CD 70R Novel Glutamatergic and Peptide Receptor Drugs as Putative Anti-Panic Agents Philip Johnson, PhD, Indiana University School of Medicine 12:00 pm – 12:30 pm | James 75C OCD: Group Pretreatment to ERP Paula Stoessel, PhD, University of California, Los Angeles 12:30 pm – 1:30 pm Lunch Lunch tickets can be purchased at Registration until noon on Friday. Lunch will be served in Grand Ballroom Salon 5. A ticket is required. If you did not purchase a lunch ticket and wish to eat outside the hotel, a list of nearby restaurants is available at Registration.

Anxiety Disorders Association of America

Saturday, March 6 1:30 pm – 2:00 pm | Essex 15R Emotional Reactivity and Regulation in Childhood Anxiety Disorders: Empirical Findings and Clinical Implications Tal Carthy, MA, Bar-Ilan University

Parental Experiences of Having a Child With Obsessive-Compulsive Disorder: Associations With Clinical Characteristics and Caregiver Adjustment Nicole Caporino, MA, University of South Florida

1:30 pm – 2:30 pm | Grand Ballroom Salon 7 56C Helping “Alphabet Soup Kids”: Challenges and Opportunities Charles Mansueto, PhD, Behavior Therapy Center of Greater Washington

The Relationship Between Maternal Care and Overprotection in the Familial Transmission of OC Symptoms Brittain Mahaffey, MA, University of North Carolina at Chapel Hill

1:30 pm – 2:30 pm | James 154C Dissemination of CBT for Anxiety Disorders to Psychiatry Residents and Other Trainees Lisa Wuyek, PhD, Johns Hopkins University School of Medicine, and Thröstur Björgvinsson, PhD, Houston OCD Program 1:30 pm – 2:30 pm | Grand Ballroom Salon 6 160C Implementing Prolonged Exposure (PE) for PTSD in Diverse Settings: Challenges and Opportunities Chair: Sharon Sung, PhD, Massachusetts General Hospital Implementation of Prolonged Exposure for September 11 Trauma in a Community Setting Katherine Muller, PsyD, Albert Einstein College of Medicine/Montefiore Medical Center Cultural Adaptations of Prolonged Exposure: Two Cases From a Community Mental Health Clinic Sharon Sung, PhD, Massachusetts General Hospital Integrating Prolonged Exposure and Dialectical Behavior Therapy to Treat Severe Cases Luana Marques, PhD, Massachusetts General Hospital/Harvard Medical School Discussant: Michael Otto, PhD, Boston University

Discussant: Martin Franklin, PhD, University of Pennsylvania School of Medicine 1:30 pm – 3:00 pm | Galena 155R Genetic Factors and Frontal-StriatalThalamic Circuit Dysfunction in Pediatric Obsessive-Compulsive Disorder Chair: Jennifer Britton, PhD, National Institute of Mental Health A Genome-Wide Association Study of Obsessive-Compulsive Disorder S. Evelyn Stewart, MD, Massachusetts General Hospital/McLean Hospital/Harvard Medical School Orbitofrontal Cortex Shows Divergent Patterns Across Inhibitory Tasks in Pediatric ObsessiveCompulsive Disorder (OCD) Jennifer Britton, PhD, National Institute of Mental Health Performance Monitoring Dysfunction in Pediatric Obsessive-Compulsive Disorder Kate D. Fitzgerald, MD, University of Michigan Increased Error-Related Brain Activity and Age at Onset in Pediatric Obsessive-Compulsive Disorder Gregory Hanna, MD, University of Michigan Discussant: Scott Rauch, MD, McLean Hospital

1:30 pm – 3:00 pm | Dover 146R Anxious Youth: The Relationship Between Parenting and Anxiety in Childhood and Young Adulthood Chair: Brittain Mahaffey, MA, University of North Carolina at Chapel Hill Investigating Adaptive and Maladaptive Aspects of Social Anxiety: A Role for the Parenting Behaviors Specific to Social Anxiety Scales (PBSSAS) Katherine Stephenson, MA, Northern Illinois University

30th Annual Conference | March 4-7, 2010

NOTE | The C and R after session numbers refer to Clinical and Research sessions.

17

Saturday, March 6 1:30 pm – 3:30 pm | Kent Research on Anxiety in Children 44R Early Risk Factors for Child Anxiety: An Ecological Model Nicholas Mian, MA, University of Massachusetts, Boston 46R Eight Years Later: A Comparison of Outcome Between CBT-Treated and Untreated Anxious Children Gili Adler Nevo, MD, Sunnybrook Health Sciences Centre 101R The Developmental Course of Anxiety Symptoms During Adolescence: The TRAILS Study Floor van Oort, PhD, ErasmusMC-Sophia 125R What the Meek May Inherit: Shyness and the Etiology of Anxiety in Childhood Robert Coplan, PhD, Carleton University 1:30 pm – 3:30 pm | Grand Ballroom Salon 8 156R Health Anxiety and Its Disorders: Theoretical and Empirical Underpinnings Associated With a DSM-V Debate Chairs: R. Nicholas Carleton, MA, and Gordon Asmundson, PhD, University of Regina Disentangling Disease Phobia, Health Anxiety, Hypochondriasis, and OCD: A Discussion of Differential Diagnoses Bradley Riemann, PhD, Rogers Memorial Hospital Is Hypochodriasis an Obsessive-Compulsive Spectrum Disorder? A Behavioral-Genetics Perspective Gordon Asmundson, PhD, University of Regina Health Anxiety, Fear, and Uncertainty R. Nicholas Carleton, MA, University of Regina Obsessive Beliefs and Anxiety Sensitivity as Predictors of Health Anxiety: Implications for DSM-V Placement Michael Wheaton, BA, University of North Carolina at Chapel Hill Discussant: Jonathan Grayson, PhD, Anxiety & OCD Treatment Center of Philadelphia

18

1:30 pm – 3:30 pm | Laurel CD 171R Psychological and Physical Sequelae of Trauma and PTSD in Urban African Americans: Convergent Data from Washington, DC, and Atlanta Cohorts Chair: Kerry Ressler, MD, PhD, Emory University Trauma, Resilience, and Recovery in a HighRisk African American Population Elaine Graves, PhD, Howard University Depression, PTSD, and Suicide in a Traumatized African American Population From Atlanta Bekh Bradley, Emory University The Role of Sleep in Psychological and Health Trauma Sequelae Tyish Brown, PhD, Howard University Physiological Correlates of Child and Adult Trauma and PTSD in an African American Population From Atlanta Tanja Jovanovic, PhD, Emory University School of Medicine Discussant: Thomas Mellman, MD, Howard University 2:00 pm – 3:30 pm | Grand Ballroom Salon 9 152R Couples-Based Interventions for Returning Veterans With PTSD Chair: Robin Weatherill, National Center for PTSD/VA Boston Healthcare System Cognitive-Behavioral Conjoint Therapy for Posttraumatic Stress Disorder: Results From an Ongoing Randomized Controlled Trial Steffany Fredman, PhD, National Center for PTSD/VA Boston Healthcare System Intimate-Partner Aggression Prevention and Cessation in Veterans With PTSD Casey Taft, PhD, National Center for PTSD/ VA Boston Healthcare System Development of a Couple-Based Intervention for PTSD in OEF/OIF Veterans Frederic Sautter, PhD, Tulane University Health Sciences Center Strong Families, Strong Forces: Emerging Findings From the Development of a Home-Based Reintegration Program for U.S. Military Families Abby Ross, MSW, Boston University School of Social Work

Anxiety Disorders Association of America

Saturday, March 6 2:00 pm – 3:30 pm | Laurel AB 157R How Do Treatments for Anxiety Disorders Benefit Patients in the Long Run? Chair: Mark Powers, PhD, University of Pennsylvania CBT Augmentation of SRI Treatment of OCD: Results of Follow-Up Edna Foa, PhD, University of Pennsylvania Improvement Over the Long Term: CPT and PE on PTSD, Depression, Health, and Guilt Patricia Resick, PhD, National Center for PTSD Predictors of Long-Term Outcome Following PE for Chronic PTSD Lori Zoellner, PhD, University of Washington Long-Term Outcomes of the Child Adolescent Anxiety Multimodal Study Anne Marie Albano, PhD, Columbia University Medical Center Discussant: H. Blair Simpson, MD, Columbia University 2:00 pm – 3:30 pm | Essex 214C Three Levels of Family Involvement in CBT for Pediatric Anxiety Disorders: Education, Coaching, and Improving Relationships Deborah Ledley, PhD, and Lynne Siqueland, PhD, Children’s Center for OCD and Anxiety; Moira Rynn, MD, New York State Psychiatric Institute/ Columbia University 2:00 pm – 5:00 pm | Grand Ballroom Salon 1, 2 219C Treating PTSD in Children and Adolescents Judith Cohen, MD, Allegheny General Hospital 2:30 pm – 3:30 pm | Iron 78C Overprotection and Overindulgence: Helping the Anxious Parent of an Anxiety Disordered Child Let Go Karen Cassiday, PhD, Anxiety & Agoraphobia Treatment Center 2:30 pm – 3:30 pm | Grand Ballroom Salon 7 132C Worried Kids and Pint-Sized Pessimists: Powerful, Practical Strategies to Buffer Children From Anxiety and Negative Thinking Tamar Chansky, PhD, Children’s Center for OCD and Anxiety 2:30 pm – 3:30 pm | Grand Ballroom Salon 3 194C Exercise for Mood and Anxiety Disorders Michael Otto, PhD, Boston University, and Jasper Smits, PhD, Southern Methodist University

30th Annual Conference | March 4-7, 2010

2:30 pm – 4:00 pm | James 180R Training Community Clinicians in Cognitive-Behavioral Therapy for Youth With Anxiety Disorders Chair: Kimberly Becker, PhD, Johns Hopkins University School of Medicine Training Practitioners in Cognitive-Behavioral Therapy for Child Anxiety: Organizational and Therapist Characteristics Prior to Training Rinad Beidas, MA, Temple University Is CBT Really Different From Usual Care? And Does It Matter? Kimberly Becker, PhD, Johns Hopkins University School of Medicine Common Factor Therapist Competence in Community Mental Health Clinics Ruth Brown, MA, Virginia Commonwealth University Discussant: Golda Ginsburg, MD, Johns Hopkins University School of Medicine 2:30 pm – 4:00 pm | Grand Ballroom Salon 6 223C What Clinicians Need to Know About Complementary and Alternative Medicine Brian Sanderoff, PD, Private Practice 3:00 pm – 3:30 pm | Dover 77R Oral Matricaria Recutita (Chamomile) Extract Therapy for Generalized Anxiety Disorder: A Double-Blind, Placebo-Controlled RCT Irene Soeller, APRN, MSN, University of Pennsylvania School of Medicine 3:00 pm – 3:30 pm | Galena 100R The Brain’s Default System in the Medial Wall of Patients With OCD Kristina Rewin Ciesielski, PhD, Massachusetts General Hospital 3:30 pm – 5:00 pm | Grand Ballroom Salon 3 195C Experiential Training in Breath-BodyMind Practices for Stress Reduction Richard Brown, MD, Columbia University College of Physicians and Surgeons, and Patricia Gerbarg, MD, New York Medical College

NOTE | The C and R after session numbers refer to Clinical and Research sessions.

19

Saturday, March 6 4:00 pm – 4:30 pm | Kent 42C Don’t Try Harder, Try Different Patrick McGrath, PhD, Alexian Brothers Behavioral Health Hospital 4:00 pm – 4:30 pm | Dover 48R Equating: One Application of ItemResponse Theory in Measuring Anxiety and Mood Disorders Felix Fischer, Dipl. Psych., Charite Universitätsmedizin Berlin 4:00 pm – 4:30 pm | Galena 122R Ventromedial Prefrontal Cortical Activation Indicative of Subjective Fear During Extinction Recall in Adolescents Jennifer Britton, PhD, National Institute of Mental Health 4:00 pm – 5:00 pm | James 187C Anxious Children With Sensory Processing Disorder Ruth Golomb, LPC, Behavior Therapy Center of Greater Washington 4:00 pm – 5:30 pm | Iron 90R How Patients With Generalized Anxiety Disorder (GAD) Are Treated in Psychiatric Care: A Pharmacoepidemiological Case Register Study in Sweden Christer Allgulander, MD, Karolinska Institutet 4:00 pm – 5:30 pm | Laurel AB 145R Anxious and in Pain: New Advances in Understanding Pain-Related Anxiety Chair: Kelsey Collimore, MA, University of Regina Fear, Anxiety, and Pain: A Comparison of Psychological Responses From Patients With Chronic Lower Back Pain and Chronic Extremity Pain R. Nicholas Carleton, MA, University of Regina Sex-Specific Effects of Pain Anxiety in a Sample of Chronic Pain Patients Margo Watt, PhD, St. Francis Xavier University

Anxiety Sensitivity, Panic, and Pain Among People Seeking Treatment for Chronic Posttraumatic Stress Disorder Jaye Wald, PhD, University of British Columbia 4:00 pm – 5:30 pm | Grand Ballroom Salon 8 153R Cultural Considerations in Anxiety Disorders: Service Utilization and Treatment Service Utilization and Satisfaction of Mental Health Services Among Latinos With Social Anxiety Disorder: Results From the National Latino and Asian American Study Luana Marques, PhD, Massachusetts General Hospital/Harvard Medical School Engagement and Retention of Adolescents of Color in Cognitive-Restructuring Therapy for Posttraumatic Stress Disorder Lisa Fortuna, MD, MPH, University of Massachusetts Medical School Targeting Anxiety Problems in Mexican-Origin and Caucasian Youth: A Preliminary CrossEthnic Comparison Armando Piña, PhD, Arizona State University The Outcome of CBT Treatment Among Cambodian Refugees: Improvement in PTSD Severity and Culturally Specific Symptoms Luana Marques, PhD, Massachusetts General Hospital/Harvard Medical School Cultural Considerations in Anxiety Disorders: Service Utilization and Treatment Roberto Lewis-Fernández, MD, Columbia University/New York State Psychiatric Institute Discussant: Roberto Lewis-Fernández, MD, Columbia University/New York State Psychiatric Institute 4:00 pm – 5:30 pm | Essex 181C A Model for Treating Early Childhood Anxiety: Rationale and Therapeutic Techniques Ashley Smith, PhD, Kansas City Center for Anxiety Treatment; Judith Jordan, PhD, Geisinger Health System; Emily Anderson, PhD, Yale University

Distinguishing Between Pain-Related Avoidance and Distress: Initial Validation of a New Clinical Scale Kelsey Collimore, MA, University of Regina

20

Anxiety Disorders Association of America

Saturday, March 6 4:00 pm – 6:00 pm | Laurel CD Research on PTSD, Genetics, and Psychoneuroendocrinology 52R Gene X Environment Interactions in Risk for PTSD in a Detroit-Area Cohort: Effects of Childhood Adversity, Social Context, and TriAllelic 5-HTTLPR Genotype Anthony King, PhD, University of Michigan 89R PTSD With Secondary Psychotic Features: A Distinct Nosological Entity? Mark Hamner, MD, Ralph H. Johnson VA Medical Center/Medical University of South Carolina 109R The Psychoneuroendocrinology of Posttraumatic Stress Disorder: Review of Serial Cerebrospinal Fluid Studies and Clinical Correlates Thomas Geracioti, MD, Cincinnati VA Medical Center/University of Cincinnati College of Medicine 4:00 pm – 6:00 pm | Grand Ballroom Salon 6 216C Troubleshooting in Cognitive-Behavioral Therapy for OCD: A Clinician’s Forum Bradley Riemann, PhD, Rogers Memorial Hospital, and Jonathan Abramowitz, PhD, University of North Carolina at Chapel Hill 4:00 pm – 6:00 pm | Grand Ballroom Salon 7 217C Undoing the Anxiety Trick: Treating Anxiety Disorders With Acceptance-Based Methods David Carbonell, PhD, Anxiety Treatment Center 4:30 pm – 5:00 pm | Dover 50R Exposure for Specific Phobia With and Without Cognitive Interventions: Different Paths to Fear Reduction An Raes, MA, Ghent University 4:30 pm – 5:30 pm | Grand Ballroom Salon 9 34C Crucial Strategies for Successful Child OCD Treatment Within the Family Jenny Yip, PsyD, Renewed Freedom Treatment Center for Rapid Anxiety Relief 5:00 pm – 5:30 pm | Dover 107R The Neural Response to Anger and Embarrassment-Mediated Social Transgressions in Generalized Social Phobia Karina Blair, PhD, National Institute of Mental Health

30th Annual Conference | March 4-7, 2010

5:00 pm – 5:30 pm | Galena 108R The Predictive Role of Anxiety Disorders in the Development of Postpartum Phenomenology Mauro Mauri, MD, University of Pisa 5:00 pm – 6:00 pm | Kent 74C OCD and Tourette’s: Two Sides of the Same Coin? Charles Mansueto, PhD, Behavior Therapy Center of Greater Washington 5:00 pm – 6:00 pm | James 206C Self-Esteem, Unconditional SelfAcceptance, and Self-Compassion: What’s the Difference and Does It Matter? Ricks Warren, PhD, University of Michigan 5:30 pm – 6:00 pm | Dover 96R On the Context-Specificity of Specific Fears and Phobias Sarah Burger, MA, University of Arizona, Tucson 5:30 pm – 6:30 pm | Boardroom Annual Conference Committee Meeting 7:00 pm – 10:00 pm Night at the Aquarium The National Aquarium in Baltimore will come to life after hours just for us. Mingle with colleagues and view more than 200 aquatic species as you tour the internationally acclaimed aquarium. Enjoy a three-course dinner buffet overlooking the water, then walk with the sharks as you wind around the main tank to the music of local band Blues Therapy. Tickets are required and can be purchased at Registration until 5 p.m. Friday. The aquarium is a short walk from the hotel. Directions are on your ticket.

NOTE | The C and R after session numbers refer to Clinical and Research sessions.

21

Sunday, March 7 SUNDAY, MARCH 7 8:30 am – 1:00 pm | Registration 7:30 am – 9:00 am | Harborside Foyer Continental Breakfast 8:00 am – 9:00 am | Waterview Ballroom CD 28C Bridging the Gap Between Science and Practice: A Proposed Model for GroupAdministered CBT for Children With Anxiety Disorders Jonathan Dalton, PhD, Behavior Therapy Center of Greater Washington 8:00 am – 9:00 am | Galena 87R Prevalence and Impact of Anxiety in Cardiovascular Disease Kenneth Yeager, PhD, Ohio State University 8:00 am – 9:00 am | Harborside Ballroom B 151C Panic Disorder-Depression Comorbidity: Clinical Implications Chairs: Ruby Castilla-Puentes, MD, DrPH, University of North Carolina at Chapel Hill/University of Pennsylvania, and Jose Luis Ayuso, MD, University Hospital San Carlos Depression and Panic Disorders: Risk Factors for Cardiovascular Disease Andres Gomez-Caminero, PhD, MPH, Bristol Myers Squibb Depression-Anxiety Comorbidity: Clinical Aspects Jose Luis Ayuso, MD, University Hospital San Carlos-Madrid Increased Risk for CHD Among Patients With Comorbid Diagnosis of Panic Disorder and Depression Ruby Castilla-Puentes, MD, DrPH, University of North Carolina at Chapel Hill/University of Pennsylvania Neurobiological Mechanisms in Panic Disorder-Depression and CHD Andrea Gomez, MD, Javeriana University Discussant: Ricardo Secin, MD, Hospital Angeles del Pedregal 8:00 am – 9:00 am | Harborside Ballroom A 218C What Clients Need to Know About Anxiety in the Brain: Enhancing Motivation and Treatment Compliance Catherine Pittman, PhD, and Elizabeth Karle, MLIS, Saint Mary’s College

22

8:00 am – 9:30 am | Iron 163C Intrusive and Repugnant Thoughts: Can They Actually Be Dangerous? Patrick McGrath, PhD, Alexian Brothers Behavioral Health Hospital; Bradley Riemann, PhD, Rogers Memorial Hospital; C. Alec Pollard, PhD, Saint Louis Behavioral Medicine Institute; Jonathan Grayson, PhD, Anxiety & Agoraphobia Treatment Center of Philadelphia; Lisa Hale, PhD, University of Kansas Medical Center; Michael Twohig, PhD, Utah State University 9:00 am – 10:00 am | Waterview Ballroom CD 38C Dissemination and Implementation of Empirically Supported Treatment for Anxious Youth in a Pediatric Hospital Tami Roblek, PhD, University of Colorado, Denver, and Christine McDunn, PhD, The Children’s Hospital 9:00 am – 10:30 am | Falkland 148R Barriers to Treatment Utilization and Research Participation Among Ethnic Minorities With Anxiety Disorders Chair: Luana Marques, PhD, Massachusetts General Hospital/Harvard Medical School Cross-Cultural Issues in Assessment and Identification of Obsessive-Compulsive Disorder in the Public School Setting Rene Staskal, MS, Illinois State University African American Attitudes About Participation in Anxiety Disorders Research Monnica Williams, PhD, University of Pennsylvania School of Medicine Treatment Utilization and Barriers to Treatment in Body Dysmorphic Disorder: The Role of Ethnicity Luana Marques, PhD, Massachusetts General Hospital/Harvard Medical School Assessing Anxiety Disorders in African American Families: The CAFE Project L. Kevin Chapman, PhD, University of Louisville Discussant: Sabine Wilhelm, Massachusetts General Hospital/Harvard Medical School 9:00 am – 10:30 am | James 173R Selective Mutism Update: Understanding and Overcoming Challenges in Assessment and Treatment Chairs: Courtney Keeton, PhD, and Meghan Crosby Budinger, MS, Johns Hopkins University School of Medicine

Anxiety Disorders Association of America

Sunday, March 7 Selective Mutism Overview and Clinical Case Conference Courtney Keeton, PhD, Johns Hopkins University School of Medicine

10:30 am – 11:00 am | Falkland 47C Encountering Resistance? Fire the Patient! Shane Owens, PhD, Private Practice

The Psychophysiological Assessment of Selective Mutism Deborah Beidel, PhD, University of Central Florida

10:30 am – 12:30 pm | James 198C If Buddha Had an Anxiety Disorder, He Would Practice Mindfulness Meditation Christine Molnar, PhD, META Center, Inc./La Salle University; Lee Ann Cardaciotto, PhD, La Salle University; Jennifer Lerner, PhD, La Salle University

Breaking the Silence: Utilizing CognitiveBehavioral Therapy (CBT) in Selective Mutism Sandra Mendlowitz, PhD, University of Toronto/Hospital for Sick Children The Development of Comprehensive Assessment and Treatment Procedures for Selective Mutism Richard Gallagher, PhD, New York University Child Study Center Toward a Prescriptive Treatment Approach for Children With Selective Mutism Courtney Haight, MA, University of Nevada, Las Vegas 9:30 am – 10:30 am | Iron 60C Impossible Cases and Therapeutic Magic: Dramatic Turnarounds in OCD Treatment Charles Mansueto, PhD, Behavior Therapy Center of Greater Washington, and Jonathan Grayson, PhD, Anxiety & OCD Treatment Center of Philadelphia 9:30 am – 10:30 am | Heron 97C Teaching Compassionate Assertiveness to Individuals With Anxiety Disorders and Depression Sherrie Vavrichek, LCSW-C, Behavior Therapy Center of Greater Washington 10:00 am – 11:00 am | Galena 13C A Stomach of Steel: Engineering Exposures to Treat Emetophobia Ashley Smith, PhD, Kansas City Center for Anxiety Treatment 10:00 am – 11:00 am | Waterview Ballroom CD 117C Treatment of Children With Anxiety and Comorbid ADHD Wendy Freeman, PhD, and Catherine Mancini, MD, FRCPC, McMaster University 10:00 am – 11:00 am | Galena 212C The Ubiquity of Intrusive Thoughts: Why We Have Them and What to Do About Them Ricks Warren, PhD, University of Michigan

30th Annual Conference | March 4-7, 2010

11:00 am – 12:00 pm | Falkland 111C The Synergy of a Team Approach: When Two (or More) Heads Are Better Than One Sherrie Vavrichek, LCSW-C; Brad Hufford, LCSWC; Lisa Levine, PsyD; Noah Weintraub, PsyD, Behavior Therapy Center of Greater Washington 11:00 am – 12:00 pm | Heron 112C The Use of Self-Compassion in the Treatment of Anxiety Disorders John Hart, PhD, LPC, The Menninger Clinic, and Keri Brown, MS, Houston OCD Program 11:00 am – 12:30 pm | Iron 140C A Comprehensive Weekly Group Treatment Program for OCD Elke Zuercher-White, PhD, and Robert McLellarn, PhD, Anxiety and Panic Treatment Center 11:00 am – 12:30 pm | Waterview Ballroom CD 207C Separation Anxiety in High-Risk Infants and Toddlers Carole Norris-Shortle, LCSW-C, University of Maryland; Kim Cosgrove, MSW, LSCW-C, Kennedy Krieger Institute/PACT Therapeutic Nursery; Barbara Baumgardner, PhD, University of Maryland School of Medicine 11:30 am – 12:30 pm | Galena 104C The Impact of Procrastination and Chronic Lateness on the Therapeutic Process Elspeth Bell, PhD, Behavior Therapy Center of Greater Washington

NOTE | The C and R after session numbers refer to Clinical and Research sessions.

23

Rogers Memorial Hospital congratulates the ADAA on 30 years of industry leadership ROGERS MEMORIAL HOSPITAL • Offers separate intensive residential CBT treatment services for children, teens and adults with OCD and anxiety disorders. • Offers day treatment services for teens and adults with OCD and anxiety disorders. • Offers specialized treatment for co-occurring OCD and eating disorders. • Delivers evidence-based treatment through its multidisciplinary teams.

Bradley C. Riemann, PhD, clinical director Obsessive-Compulsive Disorder Center and CBT Services

• Is trusted by many national health care plans to provide qualty, effective treatment.

Call to schedule a free phone screening or on-site tour.

Contact admissions at

800-767-4411

Learn more at

www.rogersocd.org

ADAA 30th Anniversary

30

Celebrating

years

Today we recognize anxiety disorders as the most common mental health disorders and among the most treatable. It is easy to forget how far our views have come since the first phobia meeting was held in 1978 in White Plains, New York. Among the clinicians and patients who attended the early phobia meetings were Bob Ackerman, MSW; Robert DuPont, MD (second president of ADAA); Nancy Flaxman; Arthur Hardy, MD (first president of ADAA); Dorothy Powell; Marty Seif, PhD; Claire Weekes, MD; Manuel Zane, MD; and, of course, Jerilyn Ross, MA, LICSW (third president of ADAA), as well as many others who discussed the need for a national organization to promote awareness of treatments for phobias. The new treatments, so-called contextual or exposure therapies, seemed promising. By 1980 a small dedicated group had emerged to found the Phobia Society of America (PSA). The founders could only begin to imagine what impact unraveling the mysteries of anxiety would have in terms of diagnostic practice and future treatment options. Even more remote was the dawn of the information age, when communications technology would provide patients and clinicians instant access to information from anywhere around the globe. This is the backdrop on which the last 30 years have developed.

26

Phobia Society of America members in the 1980s. From left, Reid Wilson, Ron Doctor, Joseph Wolpe, and Jerilyn Ross.

Landmark research studies coupled with the organization’s advocacy moved the field forward. Breakthroughs in neuroscience brought anxiety to the forefront as a condition where transformative, translational, and evidence-based treatment would one day emerge. Print, radio, television, and Internet media enthusiastically cover anxiety disorders and continue to raise awareness of their treatment today. ADAA’s website is accessed by millions, replacing handwritten notes and telephone calls asking for help. Dr. George Curtis, a former Board of Directors member, recalls much of the early enthusiasm.

Anxiety Disorders Association of America

ADAA 30th Anniversary

Below left, Rosalynn Carter at the 1992 Annual Conference. Below middle, Tom Insel receives a plaque from Jerilyn Ross for his leadership of the 2001 Scientific Research Symposium. Right, George Curtis, Jerilyn, and Tom Uhde in 1986.

“It rapidly became clear that exposure therapy for phobias would soon be yesterday’s news,” he said, “and to remain relevant, the Phobia Society would need to move with the development of the field, to embrace and promote the application of scientific methods to deepen our understanding of anxiety disorders, and to embrace biology as well as psychology.” To keep step with these changing views, the PSA changed its name in 1990 to the Anxiety Disorders Association of America (ADAA). The organization also expanded to include a growing cadre of basic and clinical researchers and added a rigorous scientific program to the annual conference, extending the organization’s reach. With these changes, ADAA grew to become one of the first mental health organizations to incorporate patient education, advocacy, clinician education, and dissemination of science into its mission.

30th Annual Conference | March 4-7, 2010

To this day, the organization plays a pivotal role in advancing the field by bridging the gap between research and clinical practice to help those with anxiety disorders and their families. ADAA has evolved into a unique hybrid organization with a growing professional membership of clinicians, basic and clinical scientists, clinician researchers and students, as well as consumer supporters. ADAA members have reason to be proud of what we have accomplished. Our annual conference has a growing international presence, and it’s the only one of its kind to integrate biological and psychological approaches in a program of interest to clinicians, researchers, and consumers. As we move ahead, ADAA remains a vibrant organization that will continue to build bridges and improve the lives of people suffering from anxiety and related disorders. See the next page for highlights from the past 30 years. ▶

27

ADAA 30th Anniversary Timeline 1980 | The Phobia Society of America (PSA) is created with the mission to improve the lives of people who develop irrational, frightening, and debilitating levels of anxiety.

1987 | PSA testifies before the U.S. House of Representatives to describe the nature, seriousness, and prevalence of anxiety disorders.

1990 | A new name, Anxiety Disorders Association of America, is adopted to reflect changes in the field and recognize a broader scope.

1997 | ADAA-funded report places the cost of anxiety disorders in the U.S. at more than $42 billion. 1999 | ADAA participates in a White House briefing on mental health, hosted by President Bill Clinton.

2002 | ADAA brings together international experts on acute stress and posttraumatic reactions and publishes the proceedings in Biological Psychiatry. 2004 | To advance research and treatment, ADAA convenes scientific conferences on anxiety and stress, comorbid illnesses, and treatment in primary care. 2006 | ADAA releases the first national survey on screening and treating anxiety disorders on college campuses.

2007 | Depression and Anxiety is the official journal. 2008 | Actors Howie Mandel and Tony Shalhoub create video and radio features for ADAA about getting treatment for OCD. ADAA develops a new website and materials for clinicians and consumers.

28

1991 | NIMH partners with ADAA to launch Panic Disorder Prevention and Public Education Program, a national effort to increase the awareness, education, and treatment of panic disorder.

1998 | ADAA convenes the first national conference on anxiety disorders among children and disseminates the call to action on Capitol Hill. | ADAA launches its first website, dramatically reshaping communication and public education.

2000 | ADAA and the Depression and Bipolar Support Alliance receive a Telly Award for a public service announcement about panic disorder and depression. 2003 | ADAA launches the Women’s Initiative, a public awareness campaign and the first research conference dedicated to this topic. 2005 | Donny Osmond helps ADAA promote its message of hope and help through national radio features and in-flight media on Continental Airlines. | ADAA launches National Stress Øut Week to raise awareness of the difference between stress, anxiety, and anxiety disorders and Got Anxiety?, a public education program for college students. 2010 | The second national conference on anxiety disorders in children takes place in March.

Anxiety Disorders Association of America

Tribute to Jerilyn Ross

Jerilyn Ross

was a dedicated clinician, pioneer, and trailblazer.

A creative thinker and visionary, she lived her dream of helping people with anxiety disorders get treatment to take back their lives. Think back to the mid-1970s: Jimmy Carter was elected President, disco was alive and well, and Watergate was the political scandal of the decade. There was no e-mail or Internet, no iPods or cell phones. There was no diagnostic category for anxiety disorders. And there were few treatments for phobias. Jerilyn, a native New Yorker, was a math teacher in the New York City public schools. The city was her home, but the sudden onset of a height phobia and panic attacks left her feeling scared and alone. Dr. Manuel Zane, a psychiatrist at White Plains Hospital who used novel techniques, treated Jerilyn successfully.

A Visionary Career Jerilyn’s experience left her certain that treatment could end the fear, loneliness, and helplessness of others who suffered from what would become known as anxiety disorders. She knew that the terror, irrationality, and debilitation associated with these disorders were incomprehensible to those who had not experienced them. She wanted to help people get treatment — and she did just that. She moved to Washington, D.C., and began her career as a psychotherapist, eventually opening the Ross Center for Anxiety and Related Disorders, a private practice. With Drs. Robert Dupont, Arthur Hardy, and Manuel Zane, Jerilyn founded in 1980 The Phobia Society of America, now called the Anxiety Disorders Association of America. ▶

Above, Jerilyn with ADAA co-founders and past presidents Arthur Hardy and Robert DuPont in 1985. Right, Jerilyn with current ADAA Board of Directors Chair Jerrold Rosenbaum in 2006.

30th Annual Conference | March 4-7, 2010

29

Tribute to Jerilyn

Below, Jerilyn with President Bill Clinton at the White House in 1999. Right, Jerilyn watches as performer Donny Osmond signs an ADAA poster.

The founders’ vision was to have patients, clinicians, and researchers help solve the mysteries of anxiety disorders and improve the lives of everyday people. Jerilyn believed that the synergies created by including everyone as an equal partner, listening, learning, and working together would bring this about. Through education and raising awareness, the organization could change the way anxiety disorders were perceived and treated. She was passionate about creating a rich, diverse forum. With the consumer as the focus, Jerilyn wanted the power of science to improve the lives of those who lived with an anxiety disorder. Leading ADAA Jerilyn Ross was a tireless advocate for science and training, treatment and education. For nearly 25 years she was a passionate spokesperson for ADAA at Congressional hearings, in the White House, and at the National Institute of Mental Health. She represented ADAA in lasting partnerships with NIMH, the American College of Neuropsychopharmacology, the Association for Behavioral and Cognitive Therapies, and other mental health advocacy and professional organizations.

30

She encouraged more research for better treatments and improved understanding of the disorders’ underlying mechanisms. She promoted professional training and faster translation of science to practice. She successfully built a unique foundation for ADAA. Speaking Out, Reaching Millions Jerilyn was saddened by the stories of wasted lives, years of misdiagnosis, and poor treatment. She was dismayed that debate continued about whether anxiety disorders are serious. Speaking out for those living with an anxiety disorder, those who provide treatment, and those who conduct research, Jerilyn made everyone’s voice heard. She never met most of those whose lives she touched. Through her radio show in 1987–92, she inspired many to seek treatment. She was a soughtafter expert for newspapers and magazines. As the author of two books, Triumph Over Fear and One Less Thing to Worry About, and guest on countless radio and television shows, including “Today,” “Larry King Live,” and “Oprah,” she reached millions with a simple message and ADAA’s tagline: Anxiety disorders are real, serious, and treatable.

Anxiety Disorders Association of America

Tribute to Jerilyn Ross

She also spoke to students about the satisfaction one finds as a clinician. And she explained to physicians and other health professionals the crippling and devastating effects of an anxiety disorder on patients and their loved ones, as well as the impact of anxiety on overall health. Jerilyn inspired many to become involved with ADAA and to reach out to others. She enriched us with her love of life. She shared her love of traveling, boating, skiing, and playing piano. She shared stories about her family, and as many may remember, her parents were “regulars” at the annual conference until 2001. Lasting Legacy Jerilyn was recognized for her advocacy, receiving the Patient Advocacy Award from the American Psychiatric Association (2004), Anxiety Disorder Initiative Award from the World Council on Anxiety and the World Psychiatric Association (2001), Distinguished Humanitarian Award from the American Association of Applied and Preventive Psychology (1994), and media awards from the American Association of University Women and the Mental Health Association of Northern Virginia.

melanoma. While the prognosis was poor, she beat the odds and was ready to lead ADAA in 1985. When diagnosed with breast cancer in 2001, Jerilyn attacked it with her usual positive attitude. Few attendees at the 2002 conference could have imagined that the very active Jerilyn they saw had just completed chemotherapy. With spirits high, Jerilyn worked until the end responding to reporters. Though she lost her battle with neuroendocrine cancer, we each have our own memories, and collectively we have something much bigger. Jerilyn left us her most precious treasure, ADAA, to grow and pass on to the next generation. Her legacy lives on in all of us — in those who provide treatment and do research, in all who suffer from an anxiety disorder, and in their loved ones touched by these disorders. Jerilyn’s impact is honored by each of you and your involvement with ADAA. It is up to us to nurture, grow, and carry her dream forward.

Jerilyn’s energy was endless, her passion and commitment unwavering. Not many knew that in the 1980s she was diagnosed with Jerilyn on the cover of the November 2000 issue of TEN: The Economics of Neuroscience, one of the many publications that sought her expertise.

30th Annual Conference | March 4-7, 2010

31

New Research Poster Session & Case Presentations AWARD WINNERS 1 Social Fears in Adolescence: The Role of Fear Conditioning Anneke Haddad, DPhil, University of Oxford; Shmuel Lissek, PhD, and Daniel Pine, MD, National Institute of Mental Health; Jennifery Lau, PhD, University of Oxford 2 Posttraumatic Stress Symptoms and Trauma Exposure in Youth With First Episode Bipolar Disorder Jeffrey Strawn, MD, Cincinnati Children’s Hospital Medical Center; Caleb Adler, MD; David Fleck, PhD; Dennis Hanseman, PhD; Danielle Maue, BS; Samantha Bitter, University of Cincinnati; Thomas Geracioti, MD, Cincinnati VA Medical Center; Stephen Strakowski, MD, and Melissa Delbello, MD, University of Cincinnati 3 Emotional Stroop Performance in Older Adults: Behavioral and fMRI Correlates of Generalized Anxiety Rebecca B. Price, MS, Rutgers University; Dana Eldreth, PhD, Johns Hopkins Bloomberg School of Public Health; Tor Wager, PhD, Columbia University; Jan Mohlman, PhD, Rutgers University 4 Pain-Related Anxiety: Do Avoidance and Distress Play a Differential Role? Kelsey Collimore, MA; R. Nicholas Carleton, MA; Gordon Asmundson, PhD, University of Regina 5 Dissociating Brain Networks Mediating Transient and Sustained Emotion: Implications for Anxiety Leah Somerville, PhD, Weill Cornell Medical College; Paul Whalen, PhD, Dartmouth College; BJ Casey, PhD, Weill Cornell Medical College; William Kelley, PhD, Dartmouth College 6 Association of Galanin SNPs With HPA-Axis Deregulation and Symptom Severity in Major Depressive and Anxiety Disorders Paul Unschuld, MD; Elisabeth Binder, MD, PhD; Darina Roeske, PhD; Angelika Erhardt, MD; Bertram Müller-Myhsok, MD, PhD; Florian Holsboer, MD, PhD, Max Planck Institute of Psychiatry 7 Threat of Respiratory Distress and Defense Reflex Activation: Relevance for Anxiety and Panic Bethany Wangelin, MS; Francesco Versace, PhD; Margaret Bradley, PhD; Vincent Costa, MS; Paul Davenport, PhD; Peter Lang, PhD, University of Florida

32

8 County-Level Social Environment Modifies the Association Between the 5-HTTLPR Polymorphism and Risk for PTSD and GAD Ananda Amstadter, PhD, Medical University of South Carolina; Karestan Koenen, PhD, Harvard School of Public Health; Allison Aiello, PhD, and Erin Bakshis, MPH, University of Michigan; Kenneth Ruggiero, PhD; Ron Acierno, PhD; Dean Kilpatrick, PhD, Medical University of South Carolina; Joel Gelernter, MD, Yale University; Sandro Galea, MD, University of Michigan 9 Neurocircuitry of Emotional Regulation in Iraq Combat Veterans With PTSD: Effects of Diagnosis and 5-HTTLPR Genotype Anthony King, PhD; Sarah Garfinkel, PhD; Xin Wang, MD, PhD; Rebecca Kaufman, BS; James Abelson, MD, PhD; Israel Liberzon, MD, University of Michigan 10 Demographic and Psychosocial Predictors of Resilience in Veterans of Operations Enduring Freedom and Iraqi Freedom Robert Pietrzak, PhD, MPH, and Steven Southwick, MD, National Center for PTSD/Yale School of Medicine 11 The Effect of Single Prolonged Stress, a Rodent Model of Posttraumatic Stress Disorder, on Fear Conditioning, Extinction, and Extinction Recall Sophie George, PhD; Dayan Knox, PhD; James Abelson, MD, PhD; Israel Liberzon, MD, University of Michigan 12 Neural Correlates of Anticipated Social Evaluation in Adolescence: Insights From Behavioral Inhibition and Social Anxiety Amanda Guyer, PhD, University of California, Davis; Eric Nelson, PhD, National Institute of Mental Health; Koraly Perez-Edgar, PhD, George Mason University; Daniel Pine, MD, and Monique Ernst, MD, PhD, National Institute of Mental Health; Nathan Fox, PhD, University of Maryland 13 Neural Mechanisms of Controlling Attention to Threat Cues in Generalized Social Anxiety Disorder Heide Klumpp, PhD; James Abelson, MD, PhD; Michael Angstadt, BS; Israel Liberzon, MD; K. Luan Phan, MD, University of Michigan

Anxiety Disorders Association of America

New Research Poster Session & Case Presentations 14 Difficulty Disengaging Attention in Patients With Social Phobia: Eye-Tracking Research Casey Schofield, MA, Brown University; Albrecht Inhoff, PhD, and Meredith Coles, PhD, Binghamton University

22 Training Parents to Be Good Behavior Therapists: A Case of Concurrent Treatment for Comorbid Early Childhood OCD and ODD Chelsea Ale, MS, and Elisa Krackow, PhD, West Virginia University

15 Acute Stress, Threat Processing, and PTSD Symptoms Ilan Wald, MA, Tel Aviv University; Yael Holoshiz, MS, Mount Sinai School of Medicine; Gadi Lubin, MD, Israel Defense Forces; David Muller, MD, and Dennis Charney, MD, Mount Sinai School of Medicine; Daniel Pine MD, National Institute of Mental Health; Yair Bar-Haim, PhD, Tel Aviv University

23 Skin-Picking Behavior in a 36-Year-Old Woman With Diabetes Mellitus and a Right Medial Frontal Lesion Jeffrey Bennett, MD, Southern Illinois University School of Medicine

16 Initial Follow-Up of Gamma Knife Ventral Capsulotomy for Treatment of ObsessiveCompulsive Disorder Nicole McLaughlin PhD, and Paul Malloy, PhD, Butler Hospital/Alpert Medical School of Brown University; Richard Marsland, RN, Butler Hospital; Georg Noren, MD, Rhode Island Hospital/Alpert Medical School of Brown University; Benjamin, Greenberg, MD, PhD, and Steven Rasmussen, MD, Butler Hospital/Alpert Medical School of Brown University 17 Sleep Disturbance as a Predictor of Posttraumatic Stress Disorder and Depression in Patients With Burn Injury Neda Gould PhD, Johns Hopkins University School of Medicine; Jodi McKibben, PhD, Uniformed Services University of the Health Sciences; Una McCann, MD; Shawn Mason PhD; Lauren Allen, BA; James Fauerbach, PhD, Johns Hopkins University School of Medicine 18 Pharmacological Manipulations of Nitric Oxide Signaling Influence the Acquisition and Consolidation of Fear Conditioning Jonathan Kelley, BA; Karen Anderson, MA; Yossef Itzhak, PhD, University of Miami CASE POSTERS 20 An Obsession or Delusion? OCD vs. Psychosis vs. PDD in an Adolescent Male Christine McDunn, PhD, and Tami Roblek, PhD, The Children’s Hospital 21 Seven-Year-Old With Specific Phobia and GAD With Comorbid Asperger’s Disorder Shehreen Latif, MA, and Marianne Barton, PhD, University of Connecticut

30th Annual Conference | March 4-7, 2010

24 Comorbid Treatment of PTSD and Panic Disorder in an OIF Veteran Using Concurrent Interoceptive and Imaginal Exposure Jennifer Francis, PhD, Uniformed Services University of the Health Sciences 25 Modifying Social-Skills Training for a Child With High-Functioning Autism and Comorbid Social Anxiety Jessica Moore, MA; Christopher Robertson, MA; Susan Keane, PhD; Rosemery Nelson-Gray, PhD, University of North Carolina at Greensboro 26 Integrating Religion and Spirituality Into Treatment for Late-Life Anxiety Melinda Stanley, PhD, Baylor College of Medicine; Terri Barrera, BA, and Amber Bush, MA, University of Houston; Catherine Barber, PhD, Baylor College of Medicine 27 Cognitive Distancing and Behavioral Intervention for Coping With Comorbid ObsessiveCompulsive Behavior and Myasthenia Gravis Duane Lundervold, RhD, Plaza Primary Care and Geriatrics 28 Behavioral Relaxation Training and Cognitive Restructuring for Comorbid Anxiety and Systemic Lupus Erythematosus Duane Lundervold, RhD, Plaza Primary Care and Geriatrics 29 The Relationship Between Degree of Intolerance of Uncertainty and Subtypes of Perfectionism and Coping Strategies Martin Katzman, MD; Mihaela Dirlea; Dina Tsirgielis, BS, University of Toronto; Munira Mohamed, York University; Monica Vermani, PsyD; Catherine Cameron, MD, CCFP; Irvin Epstein MD, START Clinic for Mood and Anxiety Disorders; Christina Iorio, BA, Lakehead University

33

New Research Poster Session & Case Presentations 30 Perfectionism and its Correlation Between Coping Strategies, Degree of Anxiety Sensitivity, and its Relationship to the Degree of Intolerance of Uncertainty Martin Katzman, MD; Dina Tsirgielis, BS; Mihaela Dirlea, University of Toronto; Munira Mohamed, York University; Monica Vermani, PsyD; Catherine Cameron, MD, CCFP; Irvin Epstein MD, START Clinic for Mood and Anxiety Disorders; Christina Iorio, BA, Lakehead University 31 Insular Cortical Activity During Mindfulness Meditation: An fMRI Study of Respiration Reveals Overlap With Anxiety Circuitry Karleyton Evans, MD; Tina Chou, BA; Adrienne McCallister, BA, Massachusetts General Hospital; Herbert Benson, MD, and Jeffery Dusek, PhD, Benson-Henry Institute for Mind Body Medicine; Sara Lazar, PhD, Massachusetts General Hospital 32 Integrated Treatment of Cocaine Abuse and Panic Disorder in an Opioid-Dependent Outpatient: A Case Report Amie Kolos, MS, LGPC, and Michael Kidorf, PhD, Johns Hopkins Bayview Medical Center 33 The Acoustic Startle Probe Is a Viable Exposure Protocol for PTSD: A Clinical Case Study Gordon Asmundson, PhD, and R. Nicholas Carelton, MA, University of Regina

34

37 A Patient With Posttraumatic Stress Disorder Showed Significant Improvement With Prolonged Exposure Combined With Biofeedback Jong-Min Woo, MD, PhD, MPH, Inje University Seoul-Paik Hospital; Ik-Sung Chee, PhD, Chungnam National University College of Medicine; Jong-Hyuck Choi, PhD, Republic of Korea National Medical Center; Ki-Chung Paik, PhD, Dankook University College of Medicine 38 Home-Based Prolonged Exposure: A Case Example Kathariya Mokrue, PhD, York College, City University of New York 39 Supported Employment Vocational Rehabilitation for Veterans With Posttraumatic Stress Disorder Lori Davis, MD, and Rich Toscano, MA, Tuscaloosa VA Medical Center; Pamela Parker, MD, Birmingham VA Medical Center; Tockie Hemphill, MA, and Kim Washington, MA, Tuscaloosa VA Medical Center 40 Pain Perception and Traumatic Stress: Evidence for a Robust Interdependent Relationship Patrick Welch, BA; R. Nicholas Carleton, MA; Gordon Asmundson, PhD, University of Regina

34 Obstacles and Limitations in Posttraumatic Stress Disorder Patient Recruitment Henry Yu, BS; Joan Mallinger, PhD; Stephen Sinclair, PhD; Samantha Crowe, PhD; James Blair, PhD, National Institute of Mental Health

41 The Role of Motivation in the Treatment of Obsessive-Compulsive Disorder Christina Riccardi, MS, Florida State University; Kiara Timpano, PhD, Massachusets General Hospital; Amanda Medley, BS, and Norman Schmidt, PhD, Florida State University

35 Interoceptive Exposure Plus Trauma-Related Exposure Therapy for Combat-Related Posttraumatic Stress Disorder Jaye Wald, PhD, and Steven Taylor, PhD, University of British Columbia

42 Group Behavioral Treatment for Trichotillomania and Skin Picking: A Case Presentation Johanna Kaplan, MA, The Catholic University of America; Sherrie Vavrichek, LCSW-C, Behavior Therapy Center of Greater Washington

36 Functional MR Imaging of PTSD With Dissociation Jong-Chul Yang, MD, PhD, Chonbuk National University Medical School; Ki-Chung Paik, MD, PhD, Dankook University College of Medicine; Ho-Suk Suh, MD, PhD, Pochon CHA University College of Medicine

PANIC DISORDER 43 Lower-Order Factors on the Anxiety Sensitivity Index-Revised and the Development of Panic Symptomatology During a Caffeine Biological Challenge Johanna Kaplan, MA, The Catholic University of America; Marilla Geraci, RN, MSN, National Institute of Mental Health; Diane Arnkoff, PhD, and Carol Glass, PhD, The Catholic University of America; Paul Carlson, MD, University of Utah School of Medicine; Daniel Pine, MD, National Institute of Mental Health

Anxiety Disorders Association of America

New Research Poster Session & Case Presentations 44 Frequency and Correlates of Self-Reported Adolescent Panic Attacks in Pediatrics Settings Alexander Queen, BA, and Jill Ehrenreich-May, PhD, University of Miami 45 Cardiorespiratory Instabilities Precede the Onset of Naturally Occurring Panic Attacks Alicia Meuret, PhD, Southern Methodist University 46 Impact of Avoidant Personality on Treatment Outcome Among Depressed Patients With Panic Symptoms Alison Gilbert, PhD; Jill Cyranowski, PhD; Patricia Houck, MSH; Ellen Frank, PhD, University of Pittsburgh School of Medicine 47 Quetiapine XR Augmentation Treatment of Resistant Panic Disorder Andrew Goddard, MD; Yong Wook Shin, MD, PhD; Carla Medlock, BA; Waqar Mahmud, MD, Indiana University 48 Cardiac Risk, Anxiety Sensitivity, and Exercise in Panic Disorder Angela Utschig Berry, PhD, Boston University; Jasper Smits, PhD, Southern Methodist University; Michael Otto, PhD, Boston University 49 Does Panic Attack History Predict Future Axis I Diagnoses? Daniel Capron, BA, Florida State University; Michael Zvolensky, PhD, University of Vermont; Norman Schmidt, PhD, Florida State University 50 An Intensive Weekend Treatment for Veterans With Panic Disorder Ellen Teng, PhD; Sara Bailey, PhD; Nancy Petersen, PhD; Nancy Jo Dunn, PhD; Angelic Chaison, PhD, Michael E. DeBakey VA Medical Center, Houston; Melinda Stanley, PhD, Baylor College of Medicine 51 Accuracy and the Yerkes-Dodson Law in Panic Patients and Healthy Volunteers on Caffeine and Placebo Lindsey Sankin, BA; Nina Shiffrin, BA; Marilla Geraci, RN, MSN; Daniel Pine, MD, National Institute of Mental Health 52 Anxiety Sensitivity and Response to Caffeine and Placebo in Panic Disorder Marilla Geraci, RN, MSN; David Luckenbaugh, MS; Lindsey Sankin, BA; Johanna Kaplan, PhD; Daniel Pine, MD, National Institute of Mental Health

30th Annual Conference | March 4-7, 2010

53 Controlled Crossover Study in Normal Subjects of Naloxone-Preceding-Lactate Infusions and Respiratory and Subjective Responses: Relationship to the Endogenous Opioid System, Suffocation False Alarm Theory, and Childhood Parental Loss (CPL) Maurice Preter, MD, Columbia University/New York State Psychiatric Institute/SUNY Downstate Medical Center; Sang Han Lee, PhD, Nathan S. Kline Institute for Psychiatric Research; Marina Vannucci, PhD, Rice University; Eva Petkova, PhD, New York University School of Medicine; Sinae Kim, PhD, University of Michigan; Donald Klein, MD, DSc, New York University Langone Medical Center/Nathan S. Kline Institute for Psychiatric Research/Columbia University 54 Anxiety as an Immediate Antecedent of Marijuana Use: An Analysis Using Ecological Momentary Assessment in the Natural Environment Jose Silgado, BS, Louisiana State University; Ross Crosby, PhD, and Stephen Wonderlich, PhD; University of North Dakota; Norman Schmidt, PhD, Florida State University; Julia Buckner, PhD, Louisiana State University CHILDREN & ADOLESCENTS 57 The CAFE Project: An Examination of Anxiety Disorders in African American Parents and Their Children L. Kevin Chapman, PhD; Jenny Petrie, BS; Quintin Diggs, BA; Lauren Vines, BA; Shon Goodwin, MS, University of Louisville 58 The Role of Maltreatment and Family Functioning on Internalizing Symptoms in Black Children Kelly Graling, BA; Jessica Graham, BA; Joan Liem, PhD, University of Massachusetts, Boston 59 Social Anxiety, Social Stressors, and the SelfRegulation of Emotion Adrienne Means-Christensen, PhD, and P. Niels Christensen, PhD, Radford University 60 The Relationship Between Experiential Avoidance and Anxiety Disorder in Inpatient Adolescents Amanda Venta, BA, The Menninger Clinic; Carla Sharp, PhD, University of Houston; John Hart, PhD, The Menninger Clinic

35

New Research Poster Session & Case Presentations 61 Social Skills and Academic Performance Among Anxious vs. Anxious-Aggressive Urban Youth Andrew Castro, BA; Michele Cooley-Strickland, PhD; Robert Griffin, BA, Johns Hopkins University; Lingqi Tang, PhD, University of California, Los Angeles; MerryJessica Fuerst, BA; Katherine Otte, BA; Lindsay Bynum, BA, Johns Hopkins University 62 Outcome of a Pilot Assessment and Treatment Study for Selective Mutism Beate Oerbeck, PhD, and Hanne Kristensen, MD, PhD, Centre for Child and Adolescent Mental Health, Eastern and Southern Norway 64 A Comparison of Treatment Completers and Non-Completers at a Community-Based Childhood Anxiety Specialty Clinic Candice Alfano, PhD; Adair Parr, MD; Matt Jarrett, MS; Kerri Kim, PhD; E. Blake Zakarin, BA, Children’s National Medical Center 66 Emotionality and Self-Regulation as Predictors of the Development of Anxiety Symptoms: Direct and Interactive Effects Cara Kiff, MS, and Liliana Lengua, PhD, University of Washington 67 Persistent Anxiety in Parents of Children With Cancer Corinne Sweeney, BA; Clare Spillane, BA; Kristy Ludwig, EdM, New York University; Laura Hogan, MD, New York University School of Medicine; William Carroll, MD; Amy Lerner, MA; Carrie Masia Warner, PhD, New York University 68 The Impact of Comorbid Anxiety Symptoms on Children With Mood Disorders Colleen Cummings, MA, and Mary Fristad, PhD, ABPP, Ohio State University 69 An Examination of the Practices of Canadian Anesthesiologists in Alleviating Preoperative Anxiety in Children and Adolescents Dan Lee, BA, and Kristi Wright, PhD, University of Regina; GA Finley, MD, FRCPC, FAAP, Centre for Pediatric Pain Research, Halifax; Mateen Raazi, MD, FRCPC, FAAP, University of Saskatchewan 70 Coping Strategies: Do They Play a Role in Delinquent Sexual Behaviors Among Youth? Caroline Pagé, MD, PsEd, MSc, Correctional Service Canada

36

71 Sex Modulates Deviant Affective and Inhibitory Control Responses in Anxious Adolescents Relative to Typical Adolescents Jessica Bemis, BS; Sven Mueller, PhD; Michael Hardin, MS; Veronica Temple, BA; Darcy Mandell, BA; Katherine Korelitz, BS; Christian Grillon, PhD; Shmuel Lissek, PhD; Daniel Pine, MD; Monique Ernst, MD, PhD, National Institute of Mental Health 73 Anxiety, ADHD, and Processing Speed Kate Jansen, MA; Hannah-Lise Schofield, PhD; Glen Getz, PhD, Allegheny General Hospital 74 Early Risk Factors for Child Anxiety: An Ecological Model Nicholas Mian, MA, University of Massachusetts, Boston 76 Emotion Management as a Mediator Between Parental Control and Childhood Anxiety Kathryn Moore, MSc; Christiane Creveling, MA; R. Enrique Varela, PhD; Lauren Hitt, BA; Jaimie Colica, BA, Tulane University 77 Community Violence, Anxiety, Comorbid Anxiety-Aggressiveness, and Classroom Behavior Among Urban Youth Katie Otte, BA; Michele Cooley-Strickland, PhD; Robert Griffin, BA, Johns Hopkins University; Lingqi Tang, PhD, University of California, Los Angeles; Lindsay Bynum, BA; Andrew Castro, BA; MerryJessica Fuerst, BA, Johns Hopkins University 78 Anxiety Sensitivity as a Mediator Between Symptoms of Anxiety and Externalizing Behaviors in Anxious Children Katrina Ostmeyer-Kountzman, MA, Virginia Tech; Cynthia Turk, PhD, Washburn University; Lisa Hale, PhD, and Amy Jacobsen, PhD, University of Kansas Medical Center 79 Dexamethasone Eliminates Exaggerated Fear Responses in PTSD Kerry Ressler, MD, PhD, Emory University; Bekh Bradley, PhD, Emory University, Decatur; Seth Norrholm, PhD, and Tamara Weiss, MD, Emory University; Katie Sicking, BA, Texas State University, San Antonio; Justine Phifer, BA, and Tanja Jovanovic, PhD, Emory University 80 Maternal Anxiety, Expectations, and Behaviors During Behavioral Tasks: Relation to Child Distress, Coping, and Performance Kimberly Becker, PhD, and Golda Ginsburg, PhD, Johns Hopkins University School of Medicine

Anxiety Disorders Association of America

New Research Poster Session & Case Presentations 81 Development of a Measure of Family Accommodation for Pediatric Anxiety Disorders: Preliminary Results Kristen Grabill, MS, Brown Medical School; Gary Geffken, PhD, University of Florida; Eric Storch, PhD, University of South Florida; Ayesha Lall, MD; Joseph McNamara, PhD; Sally Galanti, University of Florida; Jennifer Freeman, PhD, and Abbe Garcia, PhD, Brown Medical School 82 Why Do Mothers and Children Disagree on Ratings of Child Anxiety? The Effects of Child Age and Maternal Anxiety on Anxiety Reporting Laura Niditch, BS; R. Enrique Varela, PhD; Erin Hedemann, BS; Kathryn Moore, MS; C. Christiane Creveling, MA, Tulane University; Peter Edel, BS, University of New Orleans 83 Patterns of Anxiety Symptoms in Toddlers: Evidence of Early Differentiation Using Theoretically Derived and Statistically Derived Methods Leandra Godoy, MD, University of Massachusetts, Boston 84 Neighborhood Disorganization, Coping Style, Substance Use, and Anxiety Among Urban Youth Lindsay Bynum, BA; Michele Cooley-Strickland, PhD; Robert Griffin, BA, Johns Hopkins University; Lingqi Tang, PhD, University of California, Los Angeles; MerryJessica Fuerst, BA; Andrew Castro, BA; Katherine Otte, BA, Johns Hopkins University 85 Preliminary Investigation of Attention Retraining in Socially Phobic Youth Maria Cowart, PhD, and Thomas Ollendick, PhD, Virginia Tech 86 Evidence of a 5-HTTLPR Gene-Attachment Security Interaction in Predicting Helplessness in Five-Year-Old Children: Assessing the Developmental Origins of Risk Factors for Anxiety Katherine O’Donnell, BA, McGill University; Leslie Atkinson, PhD, Ryerson University; Alison Fleming, PhD; James Kennedy, PhD; Marla Sokolowski, PhD, University of Toronto; Ellen Moss, PhD, Université du Québec à Montréal; Helene Gaudreau, PhD, Douglas Mental Health University Institute; Ashley Wazana, MD; John Lydon, PhD; Michael Meaney, PhD; McGill University

30th Annual Conference | March 4-7, 2010

87 Anxiety Sensitivity and Risk for WeatherRelated Fears Margo Watt, PhD, and Emma MacDonald, BA, Saint Francis Xavier University 88 Why Do Anxious Children Report More Somatic Complaints? A Test of a Moderation Model With a Multiethnic Sample R. Enrique Varela, PhD; Erin Hedemann, BS; Lauren-Maloney Hensley, MS; Laura Niditch, BS; Kathryn Moore, MS; Christiane Creveling, MA, Tulane University 89 Estimates of Social Anxiety in a Community Sample of High School Students: Clinical Utility of Large School Screenings Rachel Kim, BA; Rebecca Rialon, BA; Samantha Adelsberg; Jaime Marrus; Emily Ocner, BA; Corinne Sweeney, BA; Amy Lerner, MA; Kristy Ludwig, EdM; Julie Ryan, MA; Carrie Masia Warner, PhD, New York University 90 Anxiety Disorders in the Pediatric Emergency Department: Clinical Correlates and Health Care Utilization in an Adolescent Sample Holly Ramsawh, PhD, and Murray Stein, MD, MPH, University of California, San Diego 91 Parent Versus Child Perceptions of Sleep Problems Among Children Diagnosed With Anxiety Disorders Raquel Delia Cumba, MA; Kerri Kim, PhD; Katherine Reynolds, BA; Janelle Mentrikoski, BA; Candice Alfano, PhD, Children’s National Medical Center 93 Anxiety Symptoms Among Brazilian Preschoolers: An Adaptation Study of Australian Scale Preschool Anxiety Scale (Parent Report) Wildson Silva, MS, Novo Hamburgo City Hall; Vera Figueiredo, PhD, Catholic University of Pelotas 94 Childhood Trauma in Adults With Social Anxiety Disorder and Panic Disorder: A CrossNational Study Christine Lochner, PhD, and Soraya Seedat, PhD, MRC Unit on Anxiety & Stress Disorders, Cape Town; Christer Allgulander, PhD, Karolinska Institutet; Martin Kidd, PhD, University of Stellenbosch; Dan Stein, MD, PhD, University of Cape Town; Arne Gerdner, PhD, Mid Sweden University

37

New Research Poster Session & Case Presentations 95 Comorbid Obsessive-Compulsive Personality Disorder in Obsessive-Compulsive Disorder: A Marker of Severity? Christine Lochner, PhD, MRC Unit on Anxiety & Stress Disorders, Cape Town; Paul Serebro, BA, Obsessive-Compulsive Association of South Africa; Sian Hemmings, PhD, and Craig Kinnear PhD, University of Stellenbosch; Dan Stein, MD, PhD, University of Cape Town 97 Effective Knowledge Translation to Improve Adolescent Anxiety Outcomes: From Efficacy to Effectiveness Kathryn Bennett, PhD, McMaster University; Amy Cheung, MD, Sunnybrook Hospital; Katharina Manassis, MD, Hospital for Sick Children OBSESSIVE-COMPULSIVE DISORDER 98 Changes of Regional Cerebral Blood Flow and Improvement of Clinical Symptoms by Repetitive Transcranial Magnetic Stimulation Treatment in Refractory Depression and Anxiety Disorders Jeong-Ho Chae, MD; Hyewon Lee, MD; Hyun-Kook Lim, MD; Ho-Jun Seo, MD, Catholic University of Korea 99 Synchrony of Self-Report and Psychophysiological Activation in Contamination Fear Arezou Mortazavi, EdM; Kate Wolitzky-Taylor, PhD; Jayson Mystkowski, PhD; Rena Yi, BS; Michelle Craske, PhD, University of California, Los Angeles 100 Obsessional Thoughts and Compulsive Behaviors in a Sample of Women With Postpartum Depression Brittain Mahaffey, MA; Jonathan Abramowitz, PhD; Samantha Brody, MD, MPH; Jane Lesserman, PhD; Susan Killenberg, MD; Kathrine Rinaldi, BA; Court Pedersen, PhD, University of North Carolina at Chapel Hill 101 ADHD Prevalence and Association With Compulsive Hoarding in Childhood-Onset OCD Brooke Sheppard, BA, University of California, San Francisco

102 Changes in Regional Cerebral Glucose Metabolism as Measured Using FDG-PET Following Deep Brain Stimulation in Patients With Obsessive-Compulsive Disorder and Major Depressive Disorder Darin Dougherty, MD, and Thilo Deckersbach, PhD, Massachusetts General Hospital; Donald Malone, MD, The Cleveland Clinic; Ali Rezai, MD, Ohio State University Medical Center; Emad Eskandar, MD, Massachusetts General Hospital; Suzanne Haber, PhD, University of Rochester; Paul Stypulkowski, PhD, and Mark Rise, PhD, Medtronic, Inc.; Steven Rasmussen, MD, Brown Medical School/Butler Hospital; Scott Rauch, MD, McLean Hospital/Massachusetts General Hospital; Benjamin Greenberg, MD, PhD, Brown Medical School/Butler Hospital 103 General Stressors and Compulsive Hoarding: The Role of Social Anxiety Symptoms Jennifer Martinez, Florida State University; Kiara Timpano, PhD, Massachussets General Hospital; Stephanie Preston, PhD, University of Michigan; Jordana Muroff, PhD, Boston University; Norman Schmidt, PhD, Florida State University 104 Muscle Dysmorphia in College Weightlifters: A Cross-Cultural Phenomenon Joseph Giardino Kepner, BS, and Mary Procidano, PhD, Fordham University 105 Symptom-Based Cluster Typology and Drug Treatment Outcome of OCD Ki-Chung Paik, MD, PhD, Dankook University School of Medicine; Jong-Chul Yang, MD, PhD, Chonbuk National University Medical School 106 The Influence of Self-Control on Obsessions and Compulsions Shehreen Latif, MA, and Kimberli Treadwell, PhD, University of Connecticut 107 Development of a Behavioral Paradigm to Assess Thought-Action Fusion Laura Fabricant, BA; Noah Berman, BA; Michael Wheaton, BA; Brittain Mahaffey, BA; Jonathan Abramowitz, PhD, University of North Carolina at Chapel Hill 108 Hoarding and Obsessive-Compulsive Disorder Belief Domains: Are They Different? Laura Hayward, MS, and Meredith Coles, PhD, Binghamton University 109 Towards a Mathematical Psychiatry: Neuroeconomics and Game Theory Models of OCD Lawrence Amsel, MD, MPH, Columbia University

38

Anxiety Disorders Association of America

New Research Poster Session & Case Presentations 110 Separation Anxiety Disorder Is Associated With Onset and Severity of Obsessive-Compulsive Disorder M. M. Mroczkowski, MD; Jack Samuels, PhD; M. Grados, MD; Mark Riddle, MD; O. Joseph Bienvenu, MD; K. Y. Liang, PhD; G. Nestadt, MD, Johns Hopkins Hospital 111 Stopping a Tortoise Versus a Train: How the Gradual Onset of OCD May Facilitate Prevention Meredith Coles, PhD; Emily Cumming, BA; Jessica Schubert, BA, Binghamton University 112 A Meta-Analytic Examination of the Effects of Self-Help Treatments for OCD and Symptoms Nathaniel Van Kirk, BS, and George Clum, PhD, Virginia Tech 113 The Relationship Between Thought-Action Fusion and Motivation for Religion Noah Berman, MA; Michael Wheaton, BA; Laura Fabricant, BA; Brittain Mahaffey, MA; Caleb Pardue; Jonathan Abramowitz, PhD, University of North Carolina at Chapel Hill 114 Functional Abnormalities in the Neural Systems Underlying Obsessive-Compulsive Disorder Rachel Marsh, PhD; Blair Simpson, MD; Moira Rynn, MD; Zhishun Wang, PhD; Benjamin Gunter, BA; Bradley Peterson, MD, Columbia University Medical Center 115 Prevalence and Correlates of Sexual Orientation Obsessions in OCD Samantha Farris, BA; Monnica Williams, PhD; Edna Foa, PhD, University of Pennsylvania 116 Targeting an Underserved Population: Recruitment of African Americans With Obsessive-Compulsive Disorder Samantha Farris, BA; Michelle Capozzoli, BA; Simoné Jalon; Monnica Williams, PhD; Edna Foa, PhD, University of Pennsylvania 117 Patient Preferences for OCD Treatment Sapana Patel, PhD, Columbia University/New York State Psychiatric Institute 119 Obsessive-Compulsive Symptom Dimensions and Prepulse Inhibition of Acoustic Startle in an Analogue Sample Michael Wheaton, BA; Joseph Franklin, MA; Noah Berman, BA; Elenda Hessel, BA; Jonathan Abramowitz, PhD, University of North Carolina at Chapel Hill

30th Annual Conference | March 4-7, 2010

OLDER ADULTS 120 Social Anxiety in Late Life: A Qualitative Study of Anxiety-Evoking Situations for the Elderly Caroline Ciliberti, BS; Christine Gould, MS; Meredith Smith, MS, West Virginia University; Daniel Chorney, PhD, IWK Health Centre; Barry Edelstein, PhD, West Virginia University 121 Late-Onset Stress Symptomatology (LOSS): Distinct From PTSD? Carrie Potter, BA; Christopher Brady, PhD; Anica Pless, MA; Lynda King, PhD; Daniel King, PhD, VA Boston Healthcare System; Crystal Park, PhD, University of Connecticut; Avron Spiro, PhD, and Eve Davison, PhD, VA Boston Healthcare System 122 The Influence of Age on Symptom Expression in Anxiety Disorders Jessica Lowe, BA, University of Washington; Michelle Craske, PhD, University of California, Los Angeles; Jutta Joesch, PhD, University of Washington at Harborview Medical Center; Greer Sullivan, MD, MSPH, Central Arkansas Veterans Healthcare System; Cathy Sherbourne, PhD, RAND Corporation; Raphael Rose, PhD, University of California, Los Angeles; Denise Chavira, PhD, University of California, San Diego; Alexander Bystritsky, MD, PhD, University of California, Los Angeles; Murray Stein, MD, PhD, University of California, San Diego; Peter Roy-Byrne, MD, University of Washington GENERALIZED ANXIETY DISORDER 123 Magnitude and Direction of Change in Sleep and Appetite Patterns Differentiate Generalized Anxiety Disorder From Unipolar Depressive Disorders Amelia Aldao, MS; Elena Wright, BA; Douglas Mennin, PhD, Yale University 124 Differentiating Generalized Anxiety Disorder (GAD) From Unipolar Depressive Disorders: A Meta-Analysis Amelia Aldao, MS, and Douglas Mennin PhD, Yale University 125 The Possibility of QT Dispersion as a Neurophysiological Marker in Social Phobia Kang Seob Oh, MD, Kangbuk Samsung Hospital; Ik-Seung Chee, MD, Chungnam University Hospital; Jong Huk Choi, MD, National Medical Center, Republic of Korea; Se-Won Lim, MD, Kangbuk Samsung Hospital

39

New Research Poster Session & Case Presentations 126 Plasma Oxytocin Level Change in Patients With Social Anxiety Disorder Treated With Escitalopram: A Preliminary Study Kang Seob Oh, MD, Kangbuk Samsung Hospital; Jong Huk Choi, MD, National Medical Center, Republic of Korea; Ik-Seung Chee, MD, Chungnam University Hospital; Se-Won Lim, MD, Kangbuk Samsung Hospital

134 Generalized Anxiety Disorder, not Panic Disorder or Obsessive-Compulsive Disorder, Associated With Increased Risk for Alcohol and Marijuana Dependence in Patients With RapidCycling Bipolar Disorder Keming Gao, MD, PhD; Philip Chan, MS; David Kemp, MD; Stephen Ganocy, PhD; Joseph Calabrese, MD, Case Western Reserve University

127 Ziprasidone Treatment of Refractory Generalized Anxiety Disorder: A PlaceboControlled, Double-Blind Study Falk Lohoff, MD; Bijan Etemad, MD; Laura Mandos, PharmD; Robert Gallop, PhD; Karl Rickels, MD, University of Pennsylvania

135 Cognitive Processes Underlying the Elevated Rate of Panic Disorder Among Smokers Kenneth Abrams, PhD; Anne Merrill; Molly Bresslour; Avantika Jalan; Emily Snyder; Kelley Stevens, Carleton College

128 Optimistic Bias in Generalized Anxiety Disorder (GAD) and Generalized Social Phobia (GSP) Marcela Otero, BA; Marilla Geruci, MSN; Daniel Pine, MD; Karina Blair, PhD, National Institute of Mental Health 129 Panic Disorder Among Patients Referred for an Electrocardiogram in a Nigerian Teaching Hospital Oluyomi Esan, MBBS, and Olusegun Baiyewu, MBBS, University of Ibadan, Nigeria 130 Treatment Patterns and Costs in Patients With Generalized Anxiety Disorder (GAD): One-Year Retrospective Analysis of Data From National Registers in Sweden Rebecka Sandelin, MSc, and Ewa Ahnemark, MD, Pfizer AB; Jan Kowalski, and Christer Allgulander, MD, Karolinska Institutet COMORBIDITY 131 Anxiety, Depression, and Substance Abuse in Incarcerated Males: Results and Implications for Future Research Denise Biron, PsyD, and Judith Johnson, PhD, Regent University 132 Neuroticism and Childhood Adversity in the Risk for Depression and Anxiety Disorders Shiva Ghaed, PhD, and Emmanuel Espejo, PhD, VA San Diego Healthcare System; Natalie Castriotta, MA, and Michelle Craske, PhD, University of California, Los Angeles; Susan Mineka, PhD, and Richard Zinbarg, PhD, Northwestern University 133 Social Anxiety and Alcohol Problems: The Role of Impressions Management Julia Buckner, PhD; Anthony Ecker, BA; Jose Silgado, BA; Russell Matthews, PhD, Louisiana State University

40

136 Relationship Between Personality Traits and Mood and Anxiety Disorders in Patients With Histories of Chronic Abdominal Pain Kirsten Haman, PhD; Susanna Quasem, MD; Jennifer Blackford, PhD, Vanderbilt University Medical Center; Judy Garber, PhD, Vanderbilt University; Lynn Walker, PhD, Vanderbilt University Medical Center 137 Examining the Association Between Anxious Arousal and Anhedonic Depression Symptoms and the Number of Days Between Lapse and Relapse to Smoking During a Self-Guided Cessation Attempt Kirsten Johnson, BA; Teresa Leyro, BA; Darcy Bennett; Kate Resch; Laura Gibson, PhD; Michael Zvolensky, PhD, University of Vermont 138 Effect of Chamomile Extract in Patients With Comorbid Anxiety and Depression Matthew Shore, MS, University of Pennsylvania School of Medicine; Justine Shults, PhD, University of Pennsylvania; Irene Soeller, CRNP, University of Pennsylvania School of Medicine; Jun Mao, MD, University of Pennsylvania Health System; Jay Amsterdam, MD, University of Pennsylvania School of Medicine 139 Correlates of Impulsivity in Individuals With Anxiety Disorders Meara Weitzman, BA; Rebecca McHugh, MA; Michael Otto, PhD, Boston University 140 Clinical Correlates and Familial Aggregation of Comorbid Anxiety Disorders in Recurrent Major Depression Michael McCusker, MA, and Fernando Goes, MD, Johns Hopkins University 141 Endorsement of Over-Breathing Symptoms Across Anxiety Disorders in Primary Care Michael Reding, MA; Kate Wolitzky-Taylor, PhD; Michelle Craske, PhD, University of California, Los Angeles Anxiety Disorders Association of America

New Research Poster Session & Case Presentations 142 The Impact of Anxiety on Memory Performance Among Patients With Major Depressive Disorder Rachel Kay, BA, University of Michigan 143 Anxiety and Disruptive Behaviors: Does Anxiety Mitigate the Severity of Disruptive Behaviors Among Children With Oppositional Defiant Disorder? Scott Anderson, BS; Thorhildur Halldorsdottir, BS; Thomas Ollendick, PhD, Virginia Tech

OTHER 149 Psychotropic Medication Use Mediates the Relationship Between Obesity and Mood and Anxiety Disorders: Findings from a Nationally Representative Sample Candyce Tart, MA; Jasper Smits, PhD; David Rosenfield, PhD, Southern Methodist University; Amber Mather, MA; Christine Henrickson, BA; Jitender Sareen, MD, University of Manitoba

144 Do Positive and Negative Temperament Traits Interact in Predicting Risk for Anxiety and Depression? A Resting EEG Study of 329 ThreeYear-Olds Stewart Shankman, MD, PhD, University of Illinois, Chicago

151 Trophic Effects of Estradiol and Selective Estrogen Receptor Modulators for Anxiety and Depression Behavior, but not Proliferation in Reproductive Tissues, Involve Estrogen Receptor Beta Alicia Walf, PhD, University at Albany, SUNY; Jamie Rusconi, PhD, Taconic Inc.; Cheryl Frye, PhD, University at Albany, SUNY

145 Worry and Rumination Processes During a Self-Guided Smoking Cessation Attempt Teresa Leyro, BA; Kirsten Johnson, BA; Briana Lurie; Elizabeth McCallion; Matthew Perrone; Laura Gibson, PhD; Michael Zvolensky, PhD, University of Vermont

152 Genome-Wide Association Study of Antidepressant Treatment Emergent Suicidal Ideation Andreas Menke, MD, and Elisabeth Binder, MD, PhD, Max Planck Institute of Psychiatry; Katharina Domschke, MD, University of Muenster; Darina Roeske, PhD; Florian Holsboer, MD, PhD

146 Mediation of Symptom Changes During Inpatient Treatment for Eating Disorders: The Role of Obsessive-Compulsive Features Candyce Tart, MA, Southern Methodist University; Bunmi Olatunji, PhD, Vanderbilt University; Shona Shewmaker, PhD, and David Wall, PhD, Remuda Ranch Programs for Eating Disorders; Jasper Smits, PhD, Southern Methodist University

153 The Clinical Course of Body Dysmorphic Disorder in the Harvard/Brown Anxiety Research Project (HARP) Andri Bjornsson, PhD, Alpert Medical School of Brown University/Butler Hospital; Ingrid Dyck, MPH; Ethan Moitra, PhD; Robert Stout, PhD; Risa Weisberg, PhD; Martin Keller, MD, Alpert Medical School of Brown University; Katharine Phillips, MD, Alpert Medical School of Brown University/Butler University

147 A Test of the Relations Between Avoidance of Panic-Related Situations and Substance Use, Substance Dependence, and Depression Among Subclinical Panickers Liviu Bunaciu, MA; Matthew Feldner, PhD; Whitney Ghassani; Heidemarie Blumenthal, BA; Kimberly Babson, MA, University of Arkansas; Norman Schmidt, PhD, and Natalie SachsEricsson, PhD, Florida State University 148 A Test of the Effects of Acute Sleep Deprivation on General and Specific SelfReported Anxiety and Depressive Symptoms: An Experimental Extension Liviu Bunaciu, MA; Whitney Ghassani; Kimberly Babson, MA; Matthew Feldner, PhD; Heidemarie Blumenthal BA; Casey Trainor, MS, University of Arkansas

154 Panic Symptoms Among Bereaved College Students Benjamin Lord, BS, and Sandra Gramling, PhD, Virginia Commonwealth University 155 Effects of Anxiety on HippocampalDependent Spatial-Navigation Performance Cassie Overstreet, BA; Nicole Arkin, MS; Brian Cornwell, PhD; Christian Grillon, PhD, National Institute of Mental Health 156 Changes in the Amygdala Associated With Fear Learning in Juvenile Rats Chicora Oliver and Christoph Wiedenmayer, PhD, Columbia University 157 Predictive Roles of Religious Motivation and Religious Coping on Trait Anxiety Christi Washington, PhD, VA Connecticut Healthcare System

30th Annual Conference | March 4-7, 2010

41

New Research Poster Session & Case Presentations 158 Sequential Factor and Cluster Analyses Support Comorbid Autism Spectrum Disorder Plus Social Anxiety Phenotype in Fragile X Syndrome Dejan Budimirovic, MD, and Walter Kaufmann, MD, Johns Hopkins University 159 Effects of Worrying on Electrodermal and Cardiac Activity and Their Perception in the Laboratory Sigrun Doberenz, Dipl-Psych; Walton Roth, MD; Noemi Tesler; Sunyoung Kim, PhD, Stanford University/VA Palo Alto Healthcare System 160 Single Unit Activity in the Lateral Septum and Central Nucleus of the Amygdala of the Rat: A Model of Exposure Therapy? Earl Thomas, PhD, Bryn Mawr College; Elna Yadin, PhD, University of Pennsylvania 161 Test Anxiety, Depression, and Irrational Beliefs in College Students Grace Boyers, BS, and Denis Nissim-Sabat, PhD, University of Mary Washington 162 The Internet and Anxiety Disorders: Epidemiology of an Experience in Argentina Gustavo Bustamante, PhD, Fundacion Fobia Club, Buenos Aires 163 Dissemination of Empirically Supported Treatments: The Role of Argument Type in Shaping Clinicians’ Attitudes Heather Pelletier, BA; Heather Rasinski, MA; Kristine Brown, BA; Laura Seligman, PhD; Andrew Geers, PhD; Joseph Hovey, PhD, University of Toledo 164 Science in the Clinic: Development of Clinical Database Infrastructure Hedieh Briggs, MSW; Kevin Kerber, MD; Michelle Kaston, BS; James Abelson, MD, PhD, University of Michigan 165 Anxiety From Pregnancy Through Six Months Postpartum and Its Comorbidity With Depression Janice Goodman PhD, APRN, Massachusetts General Hospital 166 Do CAP Patients With a Lifetime Anxiety Disorder Have Poorer Health Outcomes Than CAP Patients Without an Anxiety Disorder and Healthy Controls? Joy Beck, PhD, and Angela Shears, BS, Vanderbilt Children’s Hospital; Judy Garber, PhD, Vanderbilt University; Lynn Walker, PhD, Vanderbilt Children’s Hospital

42

167 Training for an Empirically Supported Treatment: A Comparison of Therapist Satisfaction Across Training Methods Julie Edmunds, MA; Rinad Beidas, MA; Stacey Austin, BA; Mamatha Chary, BA; Kyle Peer, BA; Kayla Brehm, BA; Anna Slavachevskaya, BA; Philip Kendall, PhD, ABPP, Temple University 168 Panic Attacks in Individuals With Body Dysmorphic Disorder Katharine Phillips, MD, Alpert Medical School of Brown University/Butler University; William Menard, BA, Butler University; Andri Bjornsson, PhD, Alpert Medical School of Brown University/ Butler University 169 The Relationship Between Income and Anxiety Disorders Katherine McMillan, BA, and Gordon Asmundson, PhD, University of Regina; Tracie Afifi, PhD, and Jitender Sareen, MD, University of Manitoba 170 The Effects of Fluoxetine on Anxious Behavior in Juvenile Monkeys Following Adverse Early Rearing Experiences Kristin Szuhany, BA, National Institute of Mental Health; Khalisa Herman, MA, Eunice Kennedy Shriver National Institute of Child Health and Human Development; Emily Johnson, BA; Stephen McLaughlin, BA; Pam Noble, MA; James Winslow, PhD; Daniel Pine, MD; Eric Nelson, PhD, National Institute of Mental Health 171 Effects of a Single Bout of Aerobic Exercise on Anxiety Sensitivity Laci Zawilinski, BS; Chelsea Price, BA; Carissa Orlando, BA; Joshua Broman-Fulks, PhD, Appalachian State University 172 State Anxiety and Attention Performance Following Distracting Threat Stimuli: Facilitation or Disruption? Laura O’Toole, MD, University of Binghamton; Melanie Hong, BA, and Tracy Dennis, PhD, Hunter College, CUNY 173 Development of Anxiety After Antidepressant Use Among Depressed Veterans Zhiguo Li, PhD; Paul Pfeiffer, MD; Katherine Hoggatt, PhD; Kara Zivin, PhD, University of Michigan; Karen Downing, BS, and Dara Ganoczy, MS, Ann Arbor VA Health Services Research and Development Center of Excellence; Marcia Valenstein, MD, University of Michigan

Anxiety Disorders Association of America

New Research Poster Session & Case Presentations 174 Examining the Relationship Among Caffeine Consumption, Anxiety, Anxiety Sensitivity, and Caffeine Expectancies Lisa Notes, MA, and Laura Juliano, PhD, American University 175 Relationship Between Complicated Grief and Separation Anxiety Disorder in Adulthood in a Sample of 454 Subjects With Mood and Anxiety Disorder Matteo Muti, MD, and Lisa Lari, PsyD, University of Pisa 176 Two Comparison Studies of Body Dysmorphic Disorder Versus Social Phobia Katharine Phillips, MD, Alpert Medical School of Brown University/Butler Hospital; Megan Kelly, PhD, Edith Nourse Rogers Memorial Veterans Hospital/Alpert Medical School of Brown University; Kristy Dalrymple, PhD, and Mark Zimmerman, MD, Alpert Medical School of Brown University/Rhode Island Hospital; 177 Do Men and Women Really Differ on Emotional Variability? Meghan Keough, MS; Christina Riccardi, MS; Norman Schmidt, PhD, Florida State University 178 Experiential Avoidance and Anxiety Sensitivity in the Prediction of Health Anxiety Michael Wheaton, BA; Noah Berman, BA; Joseph Franklin, MA; Rebecca Schneider; Jonathan Abramowitz, PhD, University of North Carolina at Chapel Hill 179 An Investigation of the Relationships Between Positive Affect and the Fundamental Fears Michel Thibodeau, BA; R. Nicholas Carleton, MA; Kelsey Collimore, MA; Gordon Asmundson, PhD, University of Regina 180 Young Adults Considering Help for Anxiety or Depression: What Do Focus Groups Tell Us? Patricia Furer, PhD, University of Manitoba; Kim Ryan-Nicholls, RN, RPN, Brandon University; John Walker, PhD, and Kristin Reynolds, BA, University of Manitoba 181 Physical and Emotional Functioning in Adults and Adolescents With Chronic Functional GI Disorders With and Without Anxiety Susanna Quasem, MD; Jennifer Blackford, PhD; Kirsten Haman, PhD; Judy Garber, PhD; Lynn Walker, PhD, Vanderbilt University Medical Center

30th Annual Conference | March 4-7, 2010

182 Large-Scale Dissemination of EvidenceBased Treatments for Children: Does Training Affect Clinician Practice? Randi Dublin, MA, Hofstra University; Sandra Pimentel, PhD; Anne Marie Albano, PhD, ABPP; Kimberly Hoagwood, PhD, Columbia University/ New York State Psychiatric Institute 183 Smoking Predicts Suicidality: Results of a Ten-Year Prospective Community Study Roselind Lieb, PhD, University of Basel; Thomas Bronisch, MD, and Petra Zimmermann, PhD, Max Planck Institute of Psychiatry 184 Maternal Anxiety and Mother-Infant Communication Sara Markese, PhD, and Beatrice Beebe, PhD, New York State Psychiatric Institute; Miriam Steele, PhD, New School for Social Research; Alla Chavarga, BA; Joseph Jaffe, MD; Amy Margolis, MA; Max Malitzky, BA; Henian Chen, MD, PhD; Patricia Cohen, PhD, New York State Psychiatric Institute; Stanley Feldstein, PhD, University of Maryland, Baltimore 185 The Relation Between Pain-Coping Style and Anxiety in Adolescents and Adults With a History of Chronic Abdominal Pain Susanna Quasem, MD; Chyrstyna Kouros, PhD; Lynn Walker, PhD; Judy Garber, PhD, Vanderbilt University Medical Center 186 Development and Evaluation of a Returnto-Work Program for Persons With Anxiety Disorders: A Pilot Study Jaye Wald, PhD; Alison Stewart, MA; Izabela Schultz, PhD; Ram Randhawa, MD; Elisabeth Zoffmann, MD, University of British Columbia POSTTRAUMATIC STRESS DISORDER 187 My PTSD Is a Full-Time Job: A Descriptive Study of Work-Reentry Barriers and Assistance Needs in Chronically Unemployed Persons With PTSD Jaye Wald, PhD; Izabela Schultz, PhD; Alison Stewart, MA, University of British Columbia 188 Psychological and Functional Consequences of Occupational Blood and Body Fluid Exposure Injuries Jaye Wald, PhD, University of British Columbia; R. Nicholas Carleton, MA, University of Regina Steven Taylor, PhD, University of British Columbia; Gordon Asmundson, PhD, University of Regina; Izabela Schultz, PhD, University of British Columbia; Lee Lewis, PhD, WorkSafe BC; Jennifer Munch, BA, University of British Columbia

43

New Research Poster Session & Case Presentations 189 A Comparison of Interoceptive Exposure Therapy and Relaxation Training When Each Are Combined With Trauma-Related Exposure Therapy for Posttraumatic Stress Disorder Jaye Wald, PhD, and Steven Taylor, PhD, University of British Columbia; Kelsey Collimore, MA, University of Regina; Luigi Chiri, MA, and Claudio Sica, PhD, University of Firenze 190 Association Between DRD2 Polymorphism and Resilience Aliza Wingo, MD; Kristina Mercer, MPH; Bekh Bradley, PhD; Kerry Ressler, MD, PhD, Emory University School of Medicine 191 Are We Helping Those Who Help Us? A Review of the United States Army’s Organizational Policy, Best Practice Guidelines, and Considerations for Treatment Orientations for PTSD Amanda McCabe, BA; Bjorn Bergstrom, MA; Jacqueline Randall, BS; Christy Sutton, BA; Katie Diershaw, BA; Johan Rosqvist, PsyD, Pacific University 193 Predicting Treatment Preference for PTSD Using the Patient-Practitioner Orientation Scale Brendan Finton, BS, and Lisa Stines Doane, PhD, Cleveland State University; Dawn Johnson, PhD, University of Akron 194 An Evaluation of the Incremental Relations Between Distress Tolerance and Posttraumatic Stress Symptoms Among Trauma-Exposed Adults Carrie Potter, BA, and Anka Vujanovic, PhD, National Center for PTSD/VA Boston Healthcare System; Marcel Bonn-Miller, PhD, Center for Health Care Evaluation/National Center for PTSD/ VA Palo Alto Healthcare System; Michael Zvolensky, PhD, University of Vermont 195 Impact of Time on PTSD Symptoms Among Returning OEF/OIF Veterans Christopher Monahan, MS, University of Memphis 196 Types of Trauma History: Differences and Similarities Between Male and Female Soldiers Admitted to an Inpatient Psychiatric Unit Daniel Cox, PhD; Marjan Holloway, PhD; Daisy Rutstein, PhD; Farrah Greene, PhD; Kristen Kochanski, BS; Shannon Branlund, MS; Jeffery Martin, MS; Graham Sterling, BS, Uniformed Services University of the Health Sciences; Geoffrey Grammer, MD, Walter Reed Army Medical Center

44

197 PTSD Symptoms in a Sample of Male Vietnam Veterans: Prevalence and Associations With Diagnostic Status Darren Holowka, PhD; Brian Marx, PhD; Kathryn Wunderle, BA; Danny Kaloupek, PhD; Terence Keane, PhD, VA Boston Healthcare System 198 Predictive Utility of Cognitive Flexibility, Brooding, Worry, and Anxiety Sensitivity in Adults With PTSD David Longo, PhD, Summit Professional Education; Ashley Longo, BS, Nova Southeastern University; Laura Messier, PhD, Rhode Island Hospital 199 Perceived Dyadic Social Support and Posttraumatic Stress Symptoms Following a Motor Vehicle Accident: The Mediating Role of Negative Posttraumatic Cognitions Donald Robinaugh, MA; Hilary Weingarden, BS; Sharon Sung, PhD; Elizabeth Marks, BA; Mark Pollack, MD; Naomi Simon, MD, MSc; Luana Marques, PhD, Massachusetts General Hospital 200 Disruption of Limbic Networks in Anxiety Shaped by Childhood Emotional Maltreatment: Generalizable Pattern of Dysfunction While Processing Threat-Related Emotional Faces Gregory Fonzo, BS, San Diego State University/ University of California, San Diego; Alan Simmons, PhD; Martin Paulus, MD; Murray Stein, MD, MPH, University of California, San Diego 201 Adjunctive Heart Rate Variability Biofeedback Intervention for OIF/OEF Combat-Related PTSD: Using HRVB to Improve Attention and Immediate Memory in Veterans JP Ginsberg, PhD; Melanie Berry, MS; DA Powell, PhD, Wm. Jennings Bryan Dorn VA Medical Center 202 PTSD and Social Support Among U.S. OEF/ OIF Veterans Joah Williams, BA; Christopher Monahan, MS; Allison Ford, BS; Meghan McDevitt-Murphy, PhD, University of Memphis 203 Assessment of Stress Vulnerability Among War Veterans With the 23 QVS: A Portuguese Instrument Joao Monteiro-Ferreira, MD, University of Coimbra Hospitals; Adriano Vaz-Serra, PhD, MD, University of Coimbra School of Medicine

Anxiety Disorders Association of America

New Research Poster Session & Case Presentations 204 Intensive Treatment of Veterans With Comorbid Chronic Pain and Posttraumatic Stress Disorder (PTSD) John Otis, PhD; Terence Keane, PhD; Erica Scioli, PhD; Kristen Sanderson, MA, VA Boston Healthcare System 205 Coping and Drinking Motives in a Veteran Population Jordan Fields, BA; Meghan McDevitt-Murphy, PhD; James Murphy, PhD, University of Memphis 206 Ethnic Differences in Conditioned Physiological Fear Responses Jose Franco, MD, University of Puerto Rico; Mohamed Zeidan, BS, Harvard University; Karen Martinez, MD, MSc, and Brenda Ojeda, MD, University of Puerto Rico; Gustavo Segura, MS, Universidad Carlos Albizu; Mohammed Milad, PhD, Harvard University; Gregory Quirk, PhD, University of Puerto Rico 207 Traumatic Experiences in Patients With Histories of Chronic Abdominal Pain Compared to Healthy Controls Kirsten Haman, PhD; Angela Shears, BS; Jennifer Fuller, MA; Lynn Walker, PhD, Vanderbilt University Medical Center 208 A Treatment Feasibility Study of a Computerized Attention Retraining Approach for Posttraumatic Stress Disorder in a College Sample Kristine King, MS, and George Clum, PhD, Virginia Tech 209 PTSD, Shame, Guilt and Language Processes: Analyzing Trauma Narratives of 112 CSA Survivors Laura Pratchett, PsyD, James J. Peters VA Medical Center; Oxana Palesh, PhD, MPH, University of Rochester; Karni Ginzburg, PhD, Tel Aviv University; Catherine Classen, PhD, University of Toronto; Constance Dalenberg, PhD, Alliant University; Lisa Butler, PhD, University at Buffalo SUNY; Cheryl Koopman, PhD, and David Speigel, MD, Stanford University 210 Stress Reactivity Among Individuals Exposed to Trauma, With and Without PTSD Katie Lawson, MA; Lauren Singleton, BS; Sudie Back, PhD, Medical University of South Carolina

30th Annual Conference | March 4-7, 2010

211 Documented Traumatic Life Events for Suicide-Related Admissions at a Military Hospital Marjan Holloway, PhD; Daniel Cox, PhD; Daisy Rutstein, MA; Farrah Greene, PhD; Elisabeth Fritz, BA; Kathryn Lou, BA, Uniformed Services University of the Health Sciences; Gary Wynn, MD, Walter Reed Army Institute of Research; John Bradley, MD, Walter Reed Army Medical Center; Brianne George, BA, Uniformed Services University of the Health Sciences 212 Differential Associations Between the Dimensions of Anxiety Sensitivity and PTSD Symptom Clusters Mathew Fetzner, BA; R. Nicholas Carleton, MA; Kelsey Collimore, MA; Gordon Asmundson, PhD, University of Regina 213 Tonic Immobility Does Not Uniquely Predict PTSD Symptom Severity Murray Abrams, MA; R. Nicholas Carleton, MA; Gordon Asmundson, PhD, University of Regina 214 Predictors of Functional Impairment Among Veterans With a History of Trauma Paola Rodriguez, MA; Brian Marx, PhD; Darren Holowka, PhD; Ashley-Ann Shirai, BA; Danny Kaloupek, PhD; Terence Keane, PhD, National Center for PTSD; Paula Schnurr, PhD, National Center for PTSD/White River Junction VA Medical Center; Carole Lunney, MA, Ohio State University 215 Neural Correlates Underlying Contextual Modulation of Fear Extinction Memory in Posttraumatic Stress Disorder Sarah Garfinkel, PhD; Jessica Adams, BS; Xin Wang, PhD; Anthony King, PhD; Chandra Sripada, MD, PhD; Rebecca Kaufman, BA; Nicholas Giardino, PhD; James Abelson, MD, PhD; Israel Liberzon, MD, University of Michigan 216 Increased Weight Gain, Enhanced Fear Memory, and Increased Anxiety in Rats Fed an American Diet, but Not in Rats Fed an Atkins Diet Shyam Seetharaman, MA, and David Diamond, PhD, University of South Florida 217 Conditioned Fear Extinction in Combat and Civilian Traumatized Populations With PTSD Seth Norrholm, PhD; Tanja Jovanovic, PhD; Kerry Ressler, MD, PhD; Kelly Skelton, MD, PhD; Bekh Bradley, PhD; Erica Duncan, MD; Ilana Olin, BS, Emory University School of Medicine

45

New Research Poster Session & Case Presentations 218 P300 Abnormality of Patients With Posttraumatic Stress Disorder Seung-Hwan Lee, MD, PhD, Inje University Ilsan Paik Hospital; Sang-Woo Hahn, MD, PhD, Soon Chun Hyang University College of Medicine 219 Prolonged Exposure (PE) and Present Centered Therapy (PCT) With Returning Veterans From Afghanistan and Iraq Sheila Rauch, PhD, and Nicholas Giardino, PhD, VA Ann Arbor Healthcare System/University of Michigan; Barbara Rothbaum, PhD, Emory University; Erin Defever, BA; Erin Smith, PhD; Israel Liberzon, MD, VA Ann Arbor Healthcare System/University of Michigan 220 Assessment and Diagnosis of Anxiety Disorders During Deployment Shiva Ghaed, PhD, MPH, and Jennifer WebbMurphy, PhD, Naval Center for Combat and Operational Stress Control; Emily Schmied, MPH, Naval Health Research Center; Kimberly Schmitz, MS, Naval Center for Combat and Operational Stress Control; Gerald Larson, PhD; Terry Conway, PhD; Mike Galarneau, MS; Nathan Edwards, MA, Naval Health Research Center; Wayne Boucher, PsyD, ABPP, United States Navy; Paul Hammer, MD, Naval Center for Combat and Operational Stress Control 221 Role of Childhood Trauma in Subsequent, Adult Posttraumatic Stress Disorder Symptom Severity Valerie Scheller, BA; Kate Wolitzky-Taylor, PhD; Michelle Craske, PhD, University of California, Los Angeles; Sue Mineka, PhD, and Richard Zinbarg, PhD, Northwestern University SOCIAL ANXIETY DISORDER 222 Continuous Decrease in Fear of Negative Evaluation During Cognitive-Behavioral Group Therapy Does Not Depend on Baseline Severity of Depression or Social Anxiety in Patients With Generalized Social Phobia Amy Moustgaard, PhD; Dave Davies, PhD; Lydia Ritchie, MSc; Jakov Shlik, MD, Royal Ottawa Mental Health Centre 223 Why Suppress Anger? Social Anxiety, Anger Experience, or Alexithymia Amy Neal, BS, and C. Alix Timko, PhD, Towson University; James Herbert, PhD, Drexel University

46

224 The Social Avoidance and Distress Scale: An Exploratory Factor Analysis Assessing the Independence of Avoidance and Distress Ashley Richter, BS; Kelsey Collimore, MA; R. Nicholas Carleton, MA; Gordon Asmundson, PhD, University of Regina 225 Temperament Moderates Effect of Novelty on Amygdala and Prefrontal Cortex Response to Fear Faces Jacqueline Clauss, BA, and Jennifer Urbano Blackford, PhD, Vanderbilt University School of Medicine 226 Attentional Biases Reflect Anxiety in Avoidant Personality Disorder Christopher Crew, MS; Geraldine Downey, PhD; Kathy Berenson, PhD, Columbia University 227 Shyness and Self-Assuredness in Social Anxiety: Intolerance of Uncertainty or Fear of Negative Evaluation? Daniel Peluso, MA; R. Nicholas Carleton, MA; Kelsey Collimore, MA; Gordon Asmundson, PhD, University of Regina 228 The Diagnostic Specificity of Conditioned Fear Generalization Across the Anxiety Disorders Elizabeth Hirschhorn, BA; Shmuel Lissek, PhD; Allison Letkiewicz, BA; Dave Luckenbaugh, MA; Marilla Geraci, RN, MSN; Daniel Pine, MD; Chrsitian Grillon, PhD, National Institute of Mental Health 229 Occupational Selection and Impairment in Primary Care Patients With Social Anxiety Disorder Ethan Moitra, PhD; Courtney Beard, PhD; Risa Weisberg, PhD; Martin Keller, MD, Brown University 230 An Association Study of the Serotonin Transporter Gene Regulatory Region Polymorphism (5-HTTLPR) With Personality Traits and Psychiatric Symptoms in a Normal Healthy Korean Population Ik-Seung Chee, MD, PhD, and Jeong-Lan Kim, MD, PhD, Chungnam National University Hospital 231 Attention Bias Modification Training for Social Anxiety Jessica Schubert, BA, and Meredith Coles, PhD, Binghamton University

Anxiety Disorders Association of America

New Research Poster Session & Case Presentations 232 Willingness to Seek CBT Among NonTreatment Seekers with Social Anxiety Disorder: Relations to Motivation and Severity of Anxiety and Depression Joseph Deschamps, BA, and Jose Silgado, BA, Louisiana State University; Norman Schmidt, PhD, Florida State University; Julia Buckner, PhD, Louisiana State University 233 Differences Between African Americans and European Americans With Social Anxiety Disorder Seeking Treatment in an Anxiety Specialty Clinic Judy Wong, MA, and Richard Heimberg, PhD, Temple University 234 Social Anxiety and Avoidance in Chronic Pain: Can Pain Avoidance Behaviors Lead to Social Anxiety? Kristen Bailey, BA, Acadia University; R. Nicholas Carleton, MA, and Gordon Asmundson, PhD, University of Regina 235 Personality Traits in Social Phobia Patients: Changes After Successful Treatment Mariangela Savoia, PhD, Faculdade de Ciências Médicas da Santa Casa de São Paulo 236 A Meta-Analytic Review of School-Based Interventions for Anxiety and Depression: Characterization of the Literature Base Matthew Mychailyszyn, MA, and Philip Kendall, PhD, Temple University 237 Social Phobia and Use of the Internet for Health Information Michael Van Ameringen, MD, FRCPC; Catherine Mancini MD, FRCPC; William Simpson, BS; Beth Patterson, BScN, BEd, McMaster University

240 The Impact Caused by the Insertion of Family Members in the Treatment of the Adult Social Phobic Patient Silvia Sztamfater, PhD, and Mariangela Gentil Savoia, PhD, Centro de Atenção Integrada à Saúde Mental 241 Body Image, Eating Pathology, Social Comparison, Negative Affect, and Depressed Mood: Differential Predictors of Social Anxiety Across Genders Tejal Jakatdar, MA, MS, and Richard Heimberg, PhD, Temple University PHOBIAS 243 Recalling the Threat: Dental Anxiety in Patients Waiting for Dental Surgery Ehud Bodner, PhD, Bar-Ilan University; Iulian Iancu, MD, Beer Yaakov Hospital 244 Targeting pCO2 to Reduce Fear-Related Hyperventilation in Blood-Injury-Injection Phobia Erica Ayala, BA; Thomas Ritz, PhD; Alicia Meuret, PhD, Southern Methodist University 245 The Relations of Cognitive Beliefs, State Anxiety, and Fearfulness on Phobic Children’s Performance on a Behavioral Approach Test (BAT) Krystal Monique Lewis, MS, and Kathryn Rainey, Virginia Tech 246 Diaphragmatic Breathing During VR Flights in Aviophobia: Treatment Enhancer or Avoidance Behavior? Paul Pauli, PhD; Andreas Mühlberger, PhD; Jana Müller, PsyD; Johanna Brütting, PsyD, University of Würzburg

238 Social Anxiety and the Interpretation of Emotional Expression: The Mediating Role of Negative-Evaluation Fears Natasha Mehta, BA; Andrea Niles, BS; Lisa Burklund, MS; Michelle Craske, PhD, University of California, Los Angeles 239 Drinking as a Coping Tool for the Management of Social Anxiety Amie Schry, BA, and Susan White, PhD, Virginia Tech

30th Annual Conference | March 4-7, 2010

47

Exhibitors CNS Vital Signs Cary Rogers, VP Sales and Practice Development 398 Airport Blvd., Suite 1400 Morrisville, NC 27560 Phone 888-750-6941 | Fax 888-650-6795 [email protected] www.cnsvs.com

Houston OCD Program Saharah Shrout, Program Manager 1401 Castle Court Houston , TX 77006 Phone 713-526-5055 | Fax 713-526-3226 [email protected] www.houstonocdprogram.org

CNS Vital Signs is an easy-to-use computer testing platform that enables the rapid assessment of neurocognitive function. It provides 30+ evidence-based rating scales to help you efficiently identify symptoms, behaviors, and comorbidities to aid in the evaluation, management, and longitudinal care of patients with anxiety disorders and other psychiatric conditions.

The Houston OCD Program resides in a beautiful two-story home and offers a warm and inviting treatment environment. It offers a full continuum of care, including residential, intensive outpatient, and outpatient services. These programs are designed for clients who are not benefiting from or are unable to utilize outpatient treatment.

Defense Centers of Excellence (DCOE) Helen Boter 1401 Wilson Blvd Arlington, VA 22209 Phone 516-991-4738 | Fax 703-696-9478 [email protected] www.dcoe.health.mil DCOE assesses, validates, oversees, and facilitates prevention, resilience, identification, treatment, outreach, rehabilitation, and reintegration programs for psychological health and traumatic brain injury to ensure the DoD meets the needs of the nation’s military communities, warriors, and families. Department of Veterans Affairs, VA Boston Healthcare System Tom Allen, Program Specialist 150 S. Huntington Ave. Boston, MA 02130 Phone 857-364-5462 | Fax 857-364-4486 [email protected] National Center for PTSD: Research, Education, and Training to Improve the Lives of Veterans Fisher Wallace Laboratories Charles Fisher, President 515 Madison Ave., 5th Floor New York, NY 10022 Phone 212-688-8100 | Fax 212-371-4519 [email protected] www.fisherwallace.com

International OCD Foundation Jeff Szymanski, PhD, Executive Director 112 Water Street, Suite 501 Boston, MA 02109 Phone 617-973-5801 | Fax 617-973-5803 [email protected] www.ocfoundation.org The International OCD Foundation is a nonprofit organization whose mission is to educate the public about OCD to raise awareness and improve the quality of treatment provided; support research into the causes of and effective treatments for OCD; improve access to resources; and advocate and lobby for the OCD community. National Institute of Mental Health (NIMH) 6001 Executive Blvd, Room 8184, MSC 9663 Bethesda, MD 20892-9663 Phone 866-615-NIMH (6464) | Fax 301-443-4279 [email protected] www.nimh.nih.gov The National Institute of Mental Health (NIMH), a component of the National Institutes of Health, Department of Health & Human Services, conducts and supports behavioral research and disseminates information and publications, at no cost, that focuses on the causes, diagnosis, prevention, and treatment of mental disorders.

Researched at Harvard Medical School and featured in The Huffington Post, the Fisher Wallace Cranial Simulator provides safe, drugfree treatment of depression, insomnia, anxiety, and stress.

48

Anxiety Disorders Association of America

Exhibitors

Exhibitors

Oxford University Press Colleen McCue, Exhibits Manager 198 Madison Avenue New York, NY 10016 Phone 212-726-6000 | Fax 212-726-6494 [email protected] www.oup.com/us

Rogers Memorial Hospital Barry Thomet, Community Outreach 34700 Valley Road Oconomowoc, WI 53066 Phone 262-646-4411 | Fax 262-646-9771 [email protected] www.rogershospital.org

Featuring new titles in the TreatmentsThatWork™ series such as Treating Late-Life Depression, Exercise for Mood and Anxiety Disorders, the new edition of Overcoming Depression, and many others.

Rogers Memorial Hospital is a nationally recognized, not-for-profit behavioral health care provider offering residential and day treatment for children, teens, and adults with obsessivecompulsive disorder (OCD) and other anxiety disorders. National health plans trust Rogers Memorial to provide effective quality care, reducing out-of-pocket expenses for patients and their families.

Psychiatric Institute of Washington (PIW) Florence Hannigan, Program Director 4228 Wisconsin Ave. NW Washington, DC 20016 Phone 202-885-5752 | Fax 202-966-7374 [email protected] www.psychinstitute.com Remuda Ranch Programs Nancy Berry, National Sales Director 1 East Apache Street Wickenburg, AZ 85390 Phone 800-445-1900 | Fax 928-684-4507 [email protected] www.remudaranch.com Remuda Ranch provides intensive inpatient programs for eating and anxiety disorders. Since 1990, we have treated 9,000 patients of all beliefs through our Christian programs for women and girls utilizing the highly effective Remuda model of treatment. For additional information call 1-800-445-1900. The Retreat at Sheppard Pratt Iris Fisher, Senior Marketing Coordinator 6501 N. Charles Street Baltimore, MD 21204 Phone 410-938-3157 | Fax 410-938-3159 [email protected] www.retreatatsp.org The Retreat is a premier, self-funded psychiatric setting operated by the nationally renowned Sheppard Pratt Health System. The Retreat is designed for patients seeking a comprehensive evaluation and intensive treatment experience. The Retreat offers an elegant setting with a multidisciplinary treatment approach to a variety of psychiatric conditions.

30th Annual Conference | March 4-7, 2010

Trichotillomania Learning Center Leslie Lee, Program Coordinator 207 McPherson Street, Suite H Santa Cruz, CA 95060 Phone 831-457-1004 | Fax 831-426-4383 [email protected] http://www.trich.org Trichotillomania Learning Center is a national nonprofit organization whose mission is to improve the quality of life of children, adolescents, and adults with hair pulling, skin picking, and related body-focused behaviors through education, outreach, alliance building, and supporting research into the causes and treatment of these disorders. Wiley-Blackwell Jennifer Elliot, Exhibits Coordinator 350 Main Street Malden, MA 02148 Phone 781-388-8200 | Fax 781-338-8210 [email protected] www.wileyblackwell.com Wiley-Blackwell is the international scientific, technical, medical, and scholarly publishing business of John Wiley & Sons, with strengths in every major academic and professional field and partnerships with many of the world’s leading societies. We are the publisher of Depression and Anxiety, ADAA’s official journal. For more, please visit www.wileyblackwell.com.

49

Literature Table

Exhibitors

Biofeedback Resources International Harry L. Campbell, President 109 Croton Ave., 2nd Floor, Suite 5 Ossining, NY 10562 Phone 914-762-4646 | Fax 914-762-2281 [email protected] www.biofeedbackinternational.com

Routledge Natasha King, Marketing Coordinator 4 Park Square, Milton Park Abingdon, Oxford, England OX14 4RN Phone 44-2070173487 | Fax 44-2070176336 [email protected] www.routledge.com

Biofeeback instruments and professional training.

Routledge is an imprint of the Taylor & Francis Group, an Informa business, and is one of the world’s leading publishers of academic journals. Taylor & Francis is dedicated to the dissemination of scholarly information, drawing on expertise developed since first publishing learned journals in 1798.

EMDR Institute Robbie Dunton, Coordinator PO Box 750 Watsonville, CA 95077 Phone 831-761-1040 | Fax 831-761-1204 [email protected] www.emdr.com Eye movement desensitization and reprocessing (EMDR) is an information-processing therapy that addresses the experiential contributors of a wide range of pathologies. It attends to the past experiences that have set the groundwork for pathology; the current situations that trigger dysfunctional emotions, beliefs and sensations; and the positive experience needed to enhance future adaptive behaviors and mental health.

Stress Free Kids Rick Lite, Chief Operating Officer 3626 Woodshire Chase Marietta, GA 30066 Phone 800-841-4204 | Fax 866-302-2759 [email protected] www.stressfreekids.com Stress Free Kids has created a line of books and CDs that helps children manage stress, anxiety, and anger while improving self-esteem and a more peaceful sleep.

Hogrefe Publishing Gundula von Fintel 875 Massachusetts Ave., 7th floor Cambridge, MA 02139 Phone 866-823-4726 | Fax 617-354-6875 [email protected] www.hogrefe.com Hogrefe Publishing (www.hogrefe.com) has been a publisher of psychology books, journals, and tests for nearly 50 years. We publish Advances in Psychotherapy: Evidence-Based Practice, a series of authoritative, practice-oriented, easy-to-read, and compact guides for psychotherapists, clinical psychologists, psychiatrists, counselors and social workers, students, and trainees.

50

Anxiety Disorders Association of America

General Information GENERAL INFORMATION

The ADAA Annual Conference provides continuing education for clinicians and researchers. This conference offers a forum to share treatment information and research data, as well as individual cases. The educational format ranges from research lectures to clinical workshops. Individuals with anxiety disorders and their families are invited to participate in this professional conference to learn about the most recent research into the causes, diagnoses, and treatment of anxiety disorders. All presentations and posters are peer-reviewed. Badges are required for admission to all sessions, meals, and receptions. Please wear your badge during the conference and remember to remove it when walking outside the hotel. Business center is located on the 3rd floor.

Statement of Need

Anxiety disorders are common and crippling. They are highly comorbid with depression, substance use, and other mental disorders. Additionally, individuals with anxiety disorders report many somatic symptoms, which often results in treatment of these symptoms rather than the anxiety disorder. The lifetime incidence of the category of anxiety disorders is 28.8% among 9,282 participants in the National Comorbidity Survey Replication. Lifetime prevalence rates are 4.7% for panic disorder, 12.5% for specific phobias, 12.1% for social anxiety disorder, 5.7% for GAD, 6.8% for PTSD, and 1.6 % for OCD. Data from the same survey found that the 12-month prevalence of anxiety disorders is nearly twice that of mood disorders. Women are at a greater risk for an anxiety disorder than men. Although most patients do not seek treatment until adulthood, more than 75% experience their first symptoms before age 22. And recent research has shown that these disorders have a familial component, which is likely mediated by genetic factors.

Internet access | All ADAA hotel guests will receive free Internet in their guest rooms. The hotel provides free wireless access in the lobby. There is no Internet access available on the conference meeting levels.

While the high prevalence of anxiety disorders and their disabling nature over a lifetime should be a great enough reason to support collaborative research efforts and broadly disseminate research, there is an increasing interest in the role anxiety disorders play in predicting future illnesses and in developing preemptive and personalized interventions. Recent data suggest that a preexisting anxiety disorder is an independent risk factor for subsequent onset of suicidal ideation and attempts, especially among those ages 16 to 25. Moreover, the data clearly demonstrate that comorbid anxiety disorders amplify the risk of suicide attempts in those with mood disorders.

Message board is located near Registration. To contact conference participants, you may leave a message on the board. Incoming messages will also be posted.

Evidence-based treatments are available, but fewer than one-third of those diagnosed with an anxiety disorder report receiving treatment. Many barriers present obstacles to treatment, including the lack of available training in evidence-based treatment.

Photography/Videotaping | Attendees may not videotape, audiotape, or photograph presentations without prior permission from the chair or speaker.

With nearly half of all patients reporting somatic symptoms and comorbidity high, it is critical to translate research about the effectiveness of specific treatments and maximize outcomes in different practice settings. Features of an important key to stimulating advances to ultimately improve public health include cultivating collaboration among researchers, implementing best practices among clinicians, and discussing key areas where a better understanding of mechanisms and development of new treatments is needed.

Disclosure forms for each speaker can be viewed at Registration. Emergency information | In the event of an emergency inside the hotel, please dial “0” to request assistance. Outside the hotel, dial 911.

Poster set-up hours | Poster presenters will be able to set up their presentations on Friday, 3:00–5:00 p.m. in the Grand Ballroom. Check in with the monitor outside the ballroom or at Registration before hanging your poster. Posters must be removed by 8:00 p.m. Friday. Any posters remaining at the end of the session will not be saved. Registration will be open daily in the Convention Registration Area near the Harborside Foyer. Hours: Thursday, 8:00 a.m.– 6:00 p.m.; Friday and Saturday, 7:30 a.m.–5:00 p.m.; Sunday, 8:30 a.m.–1:00 p.m. Smoking is NOT permitted during any session, meeting, or function.

30th Annual Conference | March 4-7, 2010

Objectives

• Provide a forum for dissemination and discussion of neurobiological, pathophysiological, and behavioral research to foster the traction needed for robust scientific advances on anxiety and anxiety-related disorders. • Disseminate the latest research on evidence-based treatments and increase their use to improve outcomes, increase quality of life and productivity, and decrease suicide. • Encourage innovative and collaborative approaches to research about anxiety and anxiety-related disorders to identify early interventions and personalized approaches, especially for those in underrepresented populations and those with comorbid medical illnesses. • Engage early career scientists, students, and trainees to learn about research and evidence-based treatments to cultivate interest in new research and close the gap between the development of new interventions and their use by clinicians. • Inform the public about new scientific evidence and empirically tested treatments.

51

Continuing Education CONTINUING EDUCATION

ADAA is pleased to offer CE and CME credits to registered professionals. New this year, members do not pay an additional fee for credits, but they must fill out the form. The credits are available for an additional fee of $55 per discipline for nonmembers. Pick up a continuing education form at Registration. To receive credits, you must complete the form and mark each session you attend. This will determine how many credits you are eligible to receive. Return the completed form to Registration by Sunday at 1:00 p.m. You will receive a signed copy as your receipt.

CME Credits

Accreditation | This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Tulane University Health Sciences Center and the Anxiety Disorders Association of America (ADAA). Tulane University Health Sciences Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Designation | Tulane University Health Sciences Center designates this educational activity for a maximum of 30 AMA PRA Category 1 Credits™. Physicians should claim credit commensurate only with the extent of their participation in the activity.

A conference evaluation will be sent to you by e-mail after the conference. You must complete and return it to ADAA to receive CE/CME credits. In accordance with new rules for continuing education and in an effort to go green, we will not have paper evaluations for individual sessions.

ADAA and Tulane University Health Sciences Center present this activity for educational purposes only and do not endorse any product, content of presentation, or exhibit. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected because of their recognized expertise.

CE Credits

Disclosure | It is the policy of the Center for Continuing Education at Tulane University Health Sciences Center and ADAA to plan and implement all of its educational activities in accordance with the ACCME’s Essential Areas and Policies to ensure balance, independence, objectivity, and scientific rigor. In accordance with the ACCME 2004 Standards for Commercial Support, everyone who is in a position to control the content of an educational activity certified for AMA PRA Category 1 Credit™ is required to disclose all relevant financial relationships with any commercial interests within the past 12 months that creates a real or apparent conflict of interest. Individuals who do not disclose are disqualified from participating in a CME activity. Individuals with potential for influence or control of CME content include planners and planning committee members, authors, teachers, educational activity directors, educational partners, and others who participate, e.g. facilitators and moderators. This disclosure pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic. Any real or apparent conflicts of interest related to the content of the presentations must be resolved prior to the educational activity. Disclosure of offlabel, experimental, or investigational use of drugs or devices must also be made known to the audience.

Psychologists | ADAA is approved by the American Psychological Association to sponsor up to 33 continuing education credits for psychologists. ADAA maintains responsibility for this program and its content. CE credits for psychologists are granted on a 1 credit per contract basis. Social Workers | This program is approved by the National Association of Social Workers (provider #886437837) for 33 continuing education contact hours. Counselors | This program is approved by the National Board for Certified Counselors for 31.5 continuing education credits. This conference has been approved as a Mandatory Continuing Education for Psychologists (MCEP) provider by the California Psychological Association Accrediting Agency. ADAA has been approved to serve as a provider of CE for licensed marriage, family, and child counselors (MFCC) and licensed clinical social workers (LCSW) in California. This course meets the qualifications for continuing education for MFTs and LCSWs as required by the California Board of Behavioral Sciences.

ADAA STAFF

Alies Muskin Chief Operating Officer Sarah Gerfen Business Manager Marta Martinez Director, Meetings and Membership Sara Menase Membership Coordinator

52

Lauren Pauer Communications and Media Relations Coordinator Jean Kaplan Teichroew Director, Communications and Media Relations Nancy Toward Outreach Coordinator

Anxiety Disorders Association of America

ADAA Leadership BOARD OF DIRECTORS Chair Jerrold F. Rosenbaum, MD Massachusetts General Hospital

David Hoberman Mandeville Films

Jonathan Abramowitz, PhD University of North Carolina at Chapel Hill

Terence Keane, PhD – Secretary Boston University/National Center for PTSD

Abby Fyer, MD – Treasurer New York State Psychiatric Institute

Mark Pollack, MD Massachusetts General Hospital/ Harvard Medical School

Robert M.A. Hirschfeld, MD University of Texas Medical Branch

Barbara O. Rothbaum, PhD, ABPP Emory University School of Medicine Murray Stein, MD, MPH University of California, San Diego H. Blair Simpson, MD, PhD — ex officio Scientific Advisory Board

Karen Cassiday, PhD — ex officio Clinical Advisory Board Peter Roy-Byrne, MD — ex officio Depression and Anxiety Donny Osmond Honorary Member Willard Scott Honorary Member

SCIENTIFIC ADVISORY BOARD Chair H. Blair Simpson, MD, PhD New York State Psychiatric Institute Anne Marie Albano, PhD, ABPP Columbia University

Matthew Friedman, MD, PhD National Center for PTSD

Douglas S. Mennin, PhD Yale University

Abby Fyer, MD New York State Psychiatric Institute

Charles Nemeroff, MD, PhD University of Miami

James Abelson, MD, PhD University of Michigan

Andrew W. Goddard, MD Indiana University School of Medicine

Gordon J. G. Asmundson, PhD University of Regina

Richard Heimberg, PhD Temple University

James C. Ballenger, MD

Robert M.A. Hirschfeld, MD University of Texas Medical Branch-Galveston

Marylene Cloitre, PhD NYU Child Study Center Judith Cohen, MD Allegheny General Hospital Meredith E. Coles, PhD Binghamton University Jeremy Coplan, MD SUNY Downstate Medical Center Michelle Craske, PhD University of California, Los Angeles Larry Culpepper, MD, MPH Boston University Michael Davis, PhD Emory University School of Medicine

Dina Hirshfeld-Becker, PhD Massachusetts General Hospital Stefan G. Hofmann, PhD Boston University Eric Hollander, MD Wayne J. Katon, MD University of Washington Terence Keane, PhD Boston University/National Center for PTSD Philip Kendall, PhD Temple University Ronald C. Kessler, PhD Harvard Medical School

JoAnn Difede, PhD Weill Cornell Medical College

Joseph LeDoux, PhD New York University

Darin Dougherty, MD Massachusetts General Hospital

Eric Lenze, MD Washington University School of Medicine

Jill Ehrenreich-May, PhD University of Miami Edna Foa, PhD University of Pennsylvania Ellen Frank, PhD University of Pittsburgh

Michael R. Liebowitz, MD Medical Research Network R. Bruce Lydiard, MD, PhD Ralph H. Johnson VA Medical Center

Thomas Ollendick, PhD Virginia Tech University Michael W. Otto, PhD Boston University Martin Paulus, MD University of California, San Diego Katharine Phillips, MD Brown University John Piacentini, PhD University of California, Los Angeles Daniel S. Pine, MD National Institute of Mental Health Mark H. Pollack, MD Massachusetts General Hospital Scott Rauch, MD McLean Hospital Kerry Ressler, MD, PhD Emory University School of Medicine Bruce Rollman, MD University of Pittsburgh School of Medicine Jerrold F. Rosenbaum, MD Massachusetts General Hospital Barbara O. Rothbaum, PhD, ABPP Emory University School of Medicine

Alan Schatzberg, MD Stanford University School of Medicine Frank Schneier, MD New York State Psychiatric Institute M. Katherine Shear, MD Columbia University Naomi Simon, MD, MSc Massachusetts General Hospital Jasper Smits, PhD Southern Methodist University Jordan W. Smoller, MD, ScD Massachusetts General Hospital Murray B. Stein, MD, MPH University of California, San Diego Thomas W. Uhde, MD Medical University of South Carolina Michael Van Ameringen, MD McMaster University Karen Wagner, MD, PhD University of Texas Medical Branch John Walkup, MD Weill Cornell Medical College Risa Weisberg, PhD Brown University Myrna M. Weissman, PhD New York State Psychiatric Institute Sabine Wilhelm, PhD Massachusetts General Hospital/ Harvard Medical School

Peter Roy-Byrne, MD University of Washington

Lori Zoellner, PhD University of Washington

Joyce Robbins, LCSW, MSW

Daniel K. Winstead, MD Tulane University School of Medicine

CLINICAL ADVISORY BOARD Chair Karen Cassiday, PhD Anxiety and Agoraphobia Treatment Center Brett Deacon, PhD University of Wyoming

Philip R. Muskin, MD Columbia University Medical Center C. Alec Pollard, PhD Saint Louis Behavioral Medicine Institute

30th Annual Conference | March 4-7, 2010

Elizabeth DuPont Spencer, MSW DuPont Clinical Research

Sally Winston, PsyD Anxiety & Stress Disorders Institute of Maryland

53

Floor Plans registration escalators

elevators

4th Floor of the Baltimore Marriott Waterfront

escalators

GRAND BALLROOM

elevators

3rd Floor of the Baltimore Marriott Waterfront Please note: The Wateriew Ballroom is on the first floor (lobby level).

54

Anxiety Disorders Association of America

Save the Date

31st Annual Conference Anxiety and Related Disorders: Efficacy, Effectiveness, and Dissemination March 24-27, 2011 Marriott New Orleans New Orleans, LA

Mark Your Calendars for 2012 and 2013! 32nd Annual Conference April 12-15, 2012 Crystal Gateway Marriott Arlington, VA

33rd Annual Conference April 4-7, 2013 Hyatt Regency La Jolla La Jolla, CA

www.HoustonOCDProgram.org

(832) 298-7075

[email protected]

Houston OCD Program The Houston OCD residential program is a highly specialized treatment program for adults with severe OCD and other anxiety related disorders. We are dedicated to providing compassionate, high-quality care in a warm and inviting environment.

Our continuum of services includes:  Specialty residential treatment  Intensive outpatient program  Diagnostic/treatment consultations  Individual cognitivebehavioral therapy

Pictured from left to right. Front row: Rachel Lei, BS, Saharah Shrout, MA, Ginny Fullerton, PhD, Kim Fountain, BA. Second Row: Susan Heffelfinger, PhD, Mary Hill, BS, Keri Brown, PhD, Jelani Daniel, BS, Back Row: Angela Smith, BA, John Novak, BS, John Hart, PhD, Joyce Davidson, MD, Thröstur Björgvinsson, PhD. Not pictured: Melony Bell, AS and Brandon Sylvester, BS.

We specialize in implementing Cognitive Behavioral Therapy, particularly Exposure and Response Prevention and other effective treatment techniques for anxiety disorders. Specifically we treat disorders such as:  Obsessive-Compulsive Disorder  O/C spectrum disorders  Social phobia and other anxiety

www.HoustonOCDProgram.org

(832) 298-7075

[email protected]

We look forward to meeting you at our conference exhibit and you can visit the follow team members who will be presenting at this year’s ADAA:  

Thröstur Björgvinsson, PhD John Hart, PhD

 

Keri Brown, PhD Saharah Shrout, MA